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 Abstract 
Because tuberculosis (TB) is a public health threat that continues to elude elimination in 
the United States, there is a need to identify contributing factors that may have 
implications for targeted control measures. Molecular studies of genetic clustering are 
crucial for pinpointing these contributing factors. It is for this reason this study was 
conducted. This was a non-experimental, cross-sectional population-based molecular 
epidemiological study of TB in SC from 2005 to 2011. Its purpose was to estimate the 
proportion of  TB that may be due to recently acquired infection and to determine the risk 
factors associated with the genetic clustering of identical M. tuberculosis isolates from 
TB patients in South Carolina from 2005-2011. The analysis sample included 627 
confirmed pulmonary and/or pleural cases of TB, for which complete data on all 
covariates and a valid genotype were available. The results strongly suggested that about 
50% of TB in South Carolina is recently transmitted. The study also revealed that being 
born in the United States and Black race were independently and significantly associated 
with being part of a TB genotype cluster. The key messages of this study were as follows:  
a substantial portion of TB in South Carolina is due to recent transmission, not 
reactivation or importation, and transmission of TB in South Carolina occurs in groups 
often defined by American birth and Black race. These important findings indicate that 
most TB in South Carolina is preventable and that enhanced TB control efforts should be 
explored. The implication for positive social change is that employing targeted contact 
investigation informed by these findings could lead to decreased disease transmission. 
Future studies should explore pilot programs that investigate alternatives to the traditional 
TB contact investigation. 
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Chapter 1: Introduction to the Study 
Introduction  
The global and domestic impact of tuberculosis (TB) disease is substantial. 
According to recent estimates, the current global incidence is nearly 9.6 million people 
(WHO, 2016). While global mortality has decreased in the last decades, it remains a 
staggering 1.5 million deaths in 2014 alone. This figure is unacceptable given that most 
of these deaths are preventable (WHO, 2016). The United States is considered a country 
with comparatively low incidence, at 3.2 cases per 100,000 persons. Despite this low 
case rate and the U .S. TB program, which is often regarded as the gold standard for 
control and prevention, between 500 and 600 people die every year from TB in the 
United States. Particularly concerning are the considerable racial and ethnic disparities 
extant in TB disease impact across the United States. In 2014, the rate of TB disease in 
Blacks was 5.8 cases per 100,000 persons, which is over 7 times higher than the rate of 
TB disease in White, non-Hispanics (0.8 cases per 100,000 persons). Similarly, in 
Hispanics/Latinos, the rate of TB disease was 5.3 cases per 100,000 persons–again, over 
7 times higher than the rate of TB among White, non-Hispanics (CDC, 2016).   
The Division of Tuberculosis Elimination (DTBE) at the CDC has, as its 
primary goal, the elimination of TB in the United States, where elimination is defined as 
≤1 case/million persons (CDC, 2013). To this end, continuing research in U. S. 
populations affected by TB is imperative. Molecular studies of genotype clustering are 
important for identifying risk factors that contribute to the ongoing transmission of TB 
in the U.S.. Genotyping may facilitate quicker (a) confirmation of known contacts, (b) 
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detection of unknown contacts, or (c) revelation of transmission environments 
(Malakmadze, 2006,Yeo, 2006). This has been exemplified by clustering studies that 
have elucidated risk factors, which, in turn, serve TB prevention efforts by informing 
TB control programs where to target their limited resources (Miller, 2002; Suffys, 
1997).. The goal of this research was to estimate the proportion of South Carolina TB 
may be due to recently acquired infection, and determine the risk factors associated with 
the genetic clustering of identical M. tuberculosis. This study has implications for social 
change including to further the TB elimination goal by elucidating risk factors for 
ongoing transmission in South Carolina, thereby informing the South Carolina TB 
Control Program and potentially other states’ control efforts, particularly states with 
populations and public health resources that compare favorably to those of South 
Carolina.  
This chapter will review the problem and purpose of the study, describe the 
research questions, assumptions, limitations, commonly used terms, and describe the 
conceptual framework of the study. 
Background 
 Because traditional contact investigation often fails to reveal source cases, 
molecular epidemiology is an important adjunct to modern TB control programs (Cacho 
Calvo, 2005; Ellis, 2002). While several studies employing TB genotyping have been 
conducted, many have focused on urban areas such as Los Angeles, Vancouver, New 
York, and San Francisco (Barnes, 1997; Hernandez-Gardduno, 2002; Driver, 2006 & 
Cattamanchi, 2006, respectively) or European populations such as England, Spain, and 
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Italy (Love, 1998; Cacho Calvo, 2005; Francetti, 2010). The statewide studies in the 
U.S. have been conducted primarily in the northeast: Massachuttes, New York, and 
Maryland (Miller, 2002; Ellis, 2002; & Torgersen, 2006). The only study from the 
southeast U.S. was in Alabama on data from 17 years ago, 1994-2000 (Kempf, 2005). 
My study addresses this gap in the literature by characterizing the molecular 
epidmiology of TB in one state in the southeast United States, that of  South Carolina. It 
provided a unique opportunity to examine both natively acquired and foreign-born 
tuberculosis, increasingly merging urban and rural environments, and conspicous, 
unaddressed racial disparities in TB disease (MMWR, 2006; MMWR, 2011). Because 
TB continues to elude elimination in the U.S., there is a need to identify contributing 
factors that may have implications for targeted control measures. Molecular studies of 
clustering are crucial for pinpointing these factors. While incident cases of TB have 
decreased in South Carolina over the previous 8 years, going from 261 cases reported in 
2005 to 140 cases reported in 2011 (South Carolina DHEC, 2014), South Carolina still 
had the 15th highest case rate in the U.S. (2011) with 3 cases per 100,000 people (CDC, 
2013). Of further concern is that the epidemiology of TB in South Carolina has long 
been characterized by extreme racial and ethnic disparities. From 2009-2014, 56.4% of 
South Carolina’s TB cases were Black, 11.9% Hispanic or Latino, and 11.1% Asian, 
while Blacks, Hispanics/Latinos, and Asians comprised only 27.9, 5.1, and 1.3% of the 
state’s population, respectively (CDC, 2016). Adding to the complexity of the race issue 
is the dramatic disparity in AIDS diagnoses in South Carolina, with 69% of new AIDS 
cases in 2013 occurring in Blacks (CDC, 2015). Because TB progresses from infection 
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to disease more often and more quickly in HIV patients, it is more difficult to treat and 
more likely to lead to death in persons co-infected with AIDS, illuminating and 
targeting any interacting racial, lifestyle, and economic disparities associated with these 
comorbidities should be a priority of public health. Approaches that could be initiated 
that simultaneously address TB and HIV co-infection should be investigated.  
 Another area of increasing concern in the last decade is the emergence and 
spread of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-
TB), both of which pose a global threat to health, economic development, and national 
security, undermining the significant progress made globally and domestically to 
accomplish TB elimination (United States Government Global Tuberculosis Strategy, 
2015). South Carolina has been affected by this, having had nine cases of TB between 
2005 and 2011 that were resistant to at least one TB treatment drug, only one of which 
was MDR-TB. Fortunately, South Carolina has had no cases of XDR-TB to date. My 
study population did not contain enough drug-resistant TB to examine drug resistance 
as a covariate. However, the emergence of MDR-TB worldwide and in the U.S. 
underscores the need for comprehensive genotyping in even low-prevalence 
communities such as South Carolina. Not because genotyping is necessary to 
distinguish drug resistance (other types of laboratory tests can determine drug resistance 
without the need for a full genotype) but because genotyping facilitates identification of 
chains of transmission. When and if cases of MDR-TB and XDR-TB occur, in order to 
target inventions it will be crucial for TB control programs to understand whether these 
cases were entirely imported or imported and then locally transmitted. 
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Statement of Problem 
 TB disease is a current, relevant, and immediate public health threat of global 
concern. Households with at least one income-producing member sick with TB but 
getting treated  typically loses 3–4 months’ work and about 2% of income;  an untreated 
person with TB may lose as much as a full year of work. In the countries with the 
highest TB prevalence, which often happen to be the poorest countries, lost productivity 
due to TB may translate to 4–7% of the gross domestic product (GDP) (U.S. DOS, 
2009). In the U.S., despite sustained efforts to eliminate TB and trends reflecting 
declining incidence in the last decade, more than 9,400 new cases were diagnosed in 
2014 (CDC, 2015). Further, TB is not just a disease of adults, even in our wealthy 
modern society; children are still infected with 486 people less than 15 years old 
diagnosed in the U.S. in 2012 (CDC, 2013). TB infection in children is especially 
troubling because it represents new transmission (as opposed to latent disease), and thus 
indicates a conspicuous failure in U.S. TB control efforts. Moreover, as mentioned 
earlier, U.S. Blacks are over 7 times more likely to be diagnosed with TB than Whites 
are. Many reasons have been postulated for this disproportionately high rate of TB 
among Blacks compared to Whites, including SES, comorbidities, and genetics but it 
has yet to be entirely explained by any of those variables. SES may explain much of this 
disparity, but the relationship is complex, thus the solution will likely also be complex 
(Cantwell, 1998). 
 In order for public health to address TB’s impact on children, minority 
populations, and income and productivity, the risk factors associated with transmission 
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have to be clearly defined. Cacho-Calvo and co-authors (2005) observed that public 
health contact tracers found epidemiological links in only 85 (37.4%) of the 231 cases 
belonging to a genotype cluster, indicating that traditional contact investigation misses 
many cases (). The findings of the Cacho-Calvo study underscore how important it is 
that genotype cluster investigations accompany traditional contact investigations 
(Cacho-Calvo, 2005). A Canadian study from 2006 had similar findings and revealed 
how essential TB genotyping in children can be. Although sputum specimens can be 
extremely difficult to obtain in children, Yeo et al. (2006) were able to obtain specimens 
and successfully genotype M. tuberculosis in 38 pediatric TB cases. From genotyping, 
investigators identified 14 possible source cases. In contrast, they were only able to 
identify one possible source case from traditional contact investigation alone (Yeo, 
2006).  
Studies that have examined predictors of TB genotype clustering have had 
some success in clarifying factors associated with TB transmission. Among confirmed 
TB cases, three characteristics were found by multiple studies to be associated with 
being part of a TB genotype cluster: history of incarceration, history of alcohol abuse, 
and history of illicit drug abuse (Barnes, 1997; Ellis, 2002; Kempf, 2005; Cattamanchi, 
2006; Driver, 2006). Not coincidently, these are also characteristics associated with 
crowded, marginalized populations that may have limited access to healthcare. My 
research examined these factors and others to determine those that were significantly 
associated with being a part of an identical TB genotype cluster of two or more cases, in 
hopes of clarifying TB transmission dynamics in South Carolina. 
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Purpose of Study 
The two goals of this research were to estimate the rate of recent TB transmission 
and to determine the risk factors associated with the genetic clustering of identical M. 
tuberculosis isolates from TB patients in South Carolina from 2005-2011 by using a 
multivariable logistic regression technique to model risk factors for the binary outcome of 
being part of a TB genotype cluster, yes or no.  
Research Questions and Hypotheses 
 I developed the following research questions in order to determine the risk 
factors for TB genotype clustering, and to estimate the rate of recent transmission of TB 
in South Carolina from 2005-2011. The literature suggests that, based on population-based 
studies, TB isolates sharing identical genotype profiles (also known as clustered isolates) 
are likely from patients with recently acquired infection (Driver, 2006; Ellis, 2002). 
Therefore, the answer to Research Question 1 would approximate what proportion of TB in 
South Carolina may have been due to recent transmission. 
Research Question 1:  
a) Using the mycobacterial interspersed repetitive unit (MIRU) genotyping 
method, and spoligotyping, for cluster classification of tuberculosis cases in 
South Carolina, I estimated the proportion of TB cases that were genotyped 
clustered versus unique (hence forward referred to as “clustered versus 
singleton”)?  
b) I estimated the proportion of South Carolina TB cases that may be due to 
recently acquired infection. The following logic was applied: 
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I. For genotype clusters of only two cases: One case of the cluster was 
assumed to be a source case. One case of the cluster was assumed to 
be the recently infected case.  
II. For genotype clusters of two or more cases: One case of the cluster was 
assumed to be the source case. All other matches in the cluster were 
assumed to be due to recent transmission.  
 Thus, C - 1, were counted as recently transmitted cases, where C was the 
number of identical isolates in the cluster. This method is based on a recent 
transmission index that has been used in prior studies, RTIn-1 = (nc - c)/n, in which n is 
the total number of the studied cases, nc is the total number of cases in a cluster (size 2 
or greater) and c is the number of genotypes represented by at least two cases. Based on 
this index, patients in a cluster are considered recent transmission and non-cluster cases 
considered reactivation. The n−1 approach denies the possibility of more than one 
source case. This index has also been referred to as the “n-1 method” (Reza Allahyar 
Torkaman, 2014; Ricks, 2009). 
Research Question 2: I  determined the risk factors of genotype clustering among 
incident South Carolina TB cases from 2005 to 2011 considering the following 
hypotheses: 
H0  There is no relationship between being US-born and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being US-born and being part of 
a TB genotype cluster when controlling for other significant covariates. 
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Ha2  There is a negative relationship between being US-born and being part of 
a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between age and being part of a TB genotype 
cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between age and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between age and being part of a TB 
genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between being male and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being male and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between being male and being part of a 
TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between black race and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between black race and being part of a 
TB genotype cluster when controlling for other significant covariates. 
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Ha2  There is a negative relationship between black race and being part of a 
TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between hispanic ethnicity and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between hispanic ethnicity and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between hispanic ethnicity and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
 
H0  There is no relationship between residence in a correctional facility at the 
time of diagnosis and being part of a TB genotype cluster when 
controlling for other significant covariates. 
Ha1  There is a positive relationship between residence in a correctional 
facility at the time of diagnosis and being part of a TB genotype cluster 
when controlling for other significant covariates. 
Ha2  There is a negative relationship between residence in a correctional 
facility at the time of diagnosis and being part of a TB genotype cluster 
when controlling for other significant covariates. 
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H0  There is no relationship between homelessness within the past year and 
being part of a TB genotype cluster when controlling for other 
significant covariates. 
Ha1  There is a positive relationship between homelessness within the past 
year and being part of a TB genotype cluster when controlling for other 
significant covariates. 
Ha2  There is a negative relationship between homelessness within the past 
year and being part of a TB genotype cluster when controlling for other 
significant covariates. 
 
H0  There is no relationship between being HIV positive and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being HIV positive and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between being HIV positive and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
 
H0  There is no relationship between alcohol abuse and being part of a TB 
genotype cluster when controlling for other significant covariates. 
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Ha1  There is a positive relationship between alcohol abuse and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between alcohol abuse and being part of 
a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between illicit drug use and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between illicit drug use and being part of 
a TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between illicit drug use and being part of 
a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between injection drug use and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between injection drug use and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between injection drug use and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
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H0  There is no relationship between substance abuse and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between substance abuse and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between substance abuse and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
 
H0  There is no relationship between having prior TB disease and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
Ha1  There is a positive relationship between having prior TB disease and 
being part of a TB genotype cluster when controlling for other 
significant covariates. 
Ha2  There is a negative relationship between prior TB disease and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
 The dependent variable of interest for this study was being part of an 
identical TB genotype cluster of two or more cases. The primary independent variables 
of interest for this study (or potential risk factors) were as follows: 
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being US-born, being younger, being male, being Black, history of homelessness, 
history of incarceration, history of alcohol abuse, history of illicit drug abuse, history of 
non-injection drug use, history of injection drug use, history of substance abuse (alcohol 
and all drug abuse combined), being HIV positive, and prior TB disease.  
 Based on previous research, it was hypothesized that having the following risk 
factors could independently predict being part of a TB genotype cluster: a history of 
incarceration, born in the United States, younger age, being male, being Black, being of 
younger age, history of homelessness, HIV positive, history of alcohol abuse, and a 
history of drug use (Barnes, 1997; Ellis, 2002; Kempf, 2005; Cattamanchi, 2006; 
Driver, 2006; Moonan, 2012). 
Nature of Study 
This was a nonexperimental, cross-sectional, population-based molecular 
epidemiological study of TB in South Carolina from 2005 to 2011. All data, including 
the TB genotype results, were secondary data. South Carolina DHEC staff originally 
collected all patient information and clinical specimens. The genotyping results came 
from TB case’s isolates that were sent to a laboratory in Michigan that is under contract 
with the CDC to provide genotyping services to TB control programs in the US. 
Culture-confirmed cases of tuberculosis in South Carolina isolates' DNA patterns were 
analyzed using two polymerase-chain reaction (PCR) methods:  MIRU and  
spoligotyping. Isolates considered genetically identical by both of these methods were 
be defined as clustered—the outcome (dependent) variable of interest for this study. 
Risk factors associated with being clustered were first examined individually in a 
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bivariate model (one independent variable and the dependent variable), then in a 
multivariable logistic model using a stepwise model building approach. The criteria for 
inclusion in the multivariable regression model was a p-value of < 0.10 and the criteria 
for inclusion in the final multivariable model was a p-value of < 0.05. All analyses were 
conducted using SAS 9.3.  
Furthermore, clustered cases have traditionally been considered an indication of 
recent transmission (Driver, 2006, Ellis, 2002). This population-based, cross-sectional 
study examined the proportion of South Carolina tuberculosis that may be due to recent 
transmission, and discusses the implications of this for the South Carolina TB Control 
Program. The research population consisted of all incident cases of pulmonary and/or 
pleural, culture-confirmed TB in South Carolina from 2005 to 2011. Thorough contact 
investigations and directly observed therapy (DOT) were the standard of care for all 
cases of TB in South Carolina. During these processes, extensive case follow-up and 
data collection were performed by the staff of the South Carolina TB Control Program. 
All patients included in this study were reported to the CDC national case registry via 
the report of a verified case of tuberculosis ([RVCT], CDC DTBE, 2009 ). This form 
included 49 variables on patient demographics, laboratory test results, drug 
suceptiblities, clinical background, clinical outcomes, and risk behavior. (A copy of this 
form is included as Appendix A.) All clincial information, such as laboratory test 
results, drug suceptabilities, clinical background and outcomes, were reported by the TB 
nurse and verified by the TB consulting physician. Information on patient demographics 
and risk behavior was primarily self-reported by the patient. History of homelessness 
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was self-reported except in circumstances where the case was identified or treated in a 
homeless shelter. The TB nurse then marked this question affirmative. 
Definition of Terms 
 The following section defines terms used throughout the study. Some terms are 
discussed further in the literature review. 
1. Acid-fast bacilli (AFB):  those microorganisms that when stained retain color 
even after they have been washed in an acid solution, and may be detected under 
a microscope in a stained smear. 
2. Active TB disease: an illness, caused by bacteria called M. tuberculosis, in which 
bacteria are multiplying and attacking parts of the body, usually the lungs. A 
person with active TB disease is able to spread disease to others if the TB 
bacteria are active in the lungs or throat. The symptoms of active TB disease 
may include weakness, weight loss, fever, no appetite, chills, sweating at night, 
bad cough, pain in the chest, and coughing up blood.  
3. AIDS-defining condition: is the list of diseases published by the CDC that are 
associated with AIDS, and used worldwide as a guideline for AIDS diagnosis. 
According to the CDC definition, a patient has AIDS if he or she is infected with 
HIV and has either: 
• CD4+ T-cell count below 200 cells/µL 
• a CD4+ T-cell percentage of total lymphocytes of less than 15% 
• or one of the defining illnesses.  
17 
 
 
4. Concentric circle method:  a method of classifying and screening contacts in 
order of intensity of exposure and risk of being infected. Contacts with the most 
exposure or highest risk of infection are screened first. 
5. Congregate setting:  a setting in which a group of usually unrelated persons live 
in close physical proximity. These settings may include hospitals, long-term care 
facilities, assisted living facilities, prison, jails, or homeless shelters.  
6. Contact investigation (may be referred to as contact tracing): a procedure for 
interviewing a person who has TB disease to determine who this person may 
have exposed to TB. Then those people who may have been exposed are tested 
for latent TB infection (LTBI) and TB disease. 
7. Contacts: people exposed to someone with infectious TB disease, usually family 
members, roommates, close friends, and sometimes coworkers, classmates, 
‘drinking buddies’, illicit drug use companions, and others. 
8. Directly observed therapy (DOT): a component of TB case management that 
helps to ensure that patients adhere to treatment, where the health care worker or 
another designated individual administers and watches the patient swallow every 
dose of the prescribed drugs. 
9. Drug-resistant TB: TB caused by organisms that are unable to grow in the 
presence of a particular drug; TB that is resistant to at least one first-line anti-
tuberculosis drug. 
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10. Ethambutol (EMB): a drug used to treat TB disease; may cause vision problems. 
Ethambutol should be used cautiously in children who are too young to be 
monitored for changes in their vision. 
11. Extrapulmonary tuberculosis: TB disease where infection has spread outside the 
lungs, this may include the pleural space, the central nervous system, the 
genitourinary system, and the lymphatic system.  
12. First-line TB drugs: the initial drugs used for treating TB disease. Include 
isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and either ethambutol 
(EMB), or streptomycin (SM). 
13. Foreign-born person: a person born outside the U.S. that currently resides in the 
United States. 
14. Foreign-born tuberculosis: tuberculosis infection that was likely acquired 
outside the United States.  
15. HIV seropositivity: testing positive for the presence of HIV antibodies in the 
blood indicating infection with Human Immunodeficiency Virus. 
16. Interferon-gamma release assay (IGRA): a type of blood test that measures a 
person’s immune reactivity to M. tuberculosis by measuring release of IFN-γ. In 
the US, QuantiFERON®-TB Gold, QuantiFERON®-TB Gold In-Tube, and T-
SPOT® TB are the currently available IGRAs brands. 
17. Isolate: a sample from a specimen that was identified as a certain organism such 
as M. tuberculosis complex. 
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18. Isoniazid (INH): a drug that is used for treating LTBI and one of the drugs used 
to treat TB disease; although relatively safe, it may cause hepatitis and other 
severe adverse reaction in some patients. 
19. Latent tuberculosis infection (LTBI): a state of persistent immune response to 
stimulation by Mycobacterium tuberculosis antigens without evidence of 
clinically manifested active TB. Persons with latent TB infection do not feel sick 
and do not have any symptoms. They are infected with M. tuberculosis, but do 
not have TB disease. The only sign of TB infection is a positive reaction to the 
tuberculin skin test or TB blood test. Persons with latent TB infection are not 
infectious and cannot spread TB infection to others. 
20. Mantoux tuberculin skin test (TST): a method of testing for TB infection 
sometimes referred to as a Purified Protein Delivery test (PPD), is where a 
needle and syringe are used to inject 0.1 ml of 5 tuberculin units of liquid 
tuberculin between the layers of the skin (intradermally), typically on the 
forearm; the reaction to this test, a palpable swollen induration, is measured 48 
to 72 hours after the injection and is interpreted as positive or negative 
depending on the size of the reaction and the patient’s risk factors for TB. 
21. Miliary TB: TB infection from a histological or radiologic finding, rather than a 
site of disease. It appears on radiograph as many small, well-defined nodules 
that resemble millet seeds scattered throughout the lungs, hence the name 
“miliary.” Usually a very serious type of infection. 
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22. Multidrug-resistant TB (MDR TB): TB organism that is resistant to at least the 
drugs isoniazid and rifampin. 
23. Mycobacterial interspersed repetitive units (MIRU): comprise short tandem 
repeat structures found at multiple loci throughout the Mycobacterium tuberculosis 
genome and are used for genotyping TB pathogens. 
24. Mycobacterium tuberculosis complex (MTBC): a genetically related group of 
Mycobacterium species that can cause tuberculosis in humans, the most 
common of which is Mycobacterium tuberculosis. 
25. Nucleic acid amplification (NAA): a laboratory technique that amplifies (copies) 
DNA or RNA segments, to identify microorganisms in sputum specimens. 
26. Pleural effusion: the abnormal accumulation of fluid in the space between the 
lungs and chest wall.  
27. Polymerase-chain reaction (PCR): a biochemical technology in molecular biology 
used to amplify a single copy or a few copies of a piece of DNA across several 
orders of magnitude, generating thousands to millions of copies of a particular DNA 
sequence. 
28. Polymorphism: a natural variation in a gene, DNA sequence, or chromosome  
29. Pulmonary disease: TB disease that occurs in the lungs which accounts for most 
(about 90%) active disease. 
30. Purified protein delivery (PPD) test: a method of testing for TB infection. See 
Mantoux TST above. 
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31. Recurrence: a patient who has either a history of a (1) negative culture result 
while receiving anti-TB therapy, but then at some point after therapy is 
completed, either the culture result becomes positive for M. tuberculosis or the 
patient has clinical or radiologic deterioration that is consistent with active TB 
disease or (2) negative smear and culture result at diagnosis and while receiving 
anti-TB therapy, but then at some point after therapy is completed, either the 
patient has a culture result that is positive for M. tuberculosis or has clinical or 
radiologic deterioration that is consistent with active TB disease. 
32. Rifampin: a drug used to treat TB disease; also used for LTBI treatment. 
Rifampin may have serious side effects such as hepatitis, turning body fluids 
orange, and drug interactions. 
33. Second-line TB drugs: drugs used to treat TB that is resistant to first-line drugs 
such as capreomycin, kanamycin, ethionamide, cycloserine, ciprofloxacin, and 
amikacin. 
34. Singleton case: a TB case with an isolate that has a unique DNA fingerprint (i.e. 
does not belong to a known genotype cluster). 
35. Smear: a specimen that has been smeared upon a glass slide, stained, washed 
with acid solution, and then placed under the microscope for examination. It is 
used to detect acid-fast bacilli in a specimen. 
36. Spoligotyping: spacer oligonucleotide typing, or spoligotyping, is a rapid, 
polymerase chain reaction (PCR)-based method for genotyping strains of the 
Mycobacterium tuberculosis complex (MTB). 
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37. Sputum: phlegm from deep in the lungs, collected in a sterile container for 
processing and examination. 
38. Tuberculosis genotype cluster: two or more TB case-patients whose 
Mycobacterium tuberculosis isolates have matching spoligotyping and 12-locus 
mycobacterial interspersed repetitive unit–variable number tandem repeat 
(MIRU-VNTR). 
39. Tuberculosis genotyping: a laboratory-based genetic analysis of the bacteria that 
cause TB disease and when combined with epidemiological data has sufficient 
discriminatory power to determine TB cases likely to be in the same chain of 
transmission or conclude that cases are not related. 
40. Extreme-drug resistant TB (XDR TB): the occurrence of TB in persons whose 
M. tuberculosis isolates are resistant to isoniazid and rifampin, plus resistant to 
any fluoroquinolone and at least one of three injectable second-line drugs. 
Assumptions 
 This study was based on three assumptions. First, most of the social (sometimes 
referred to as “lifestyle”) characteristics on the RVCT were self-reported by the case. 
The characteristics were assumed true for the purposes of this study. Some studies have 
indicated that self-reported drug and alcohol use are generally underreported due to the 
stigma associated with substance use disorders (Fendrich, 2004; Mensch, 1988; 
Midanik, 1988; Romelsjo, 1995). However, no studies on the reliability and validity of 
these specific questions from the RVCT have been conducted. But because TB health 
department nurses visit their patients 2 to 3 times per week for as long as 9 months (in order to 
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provide DOT), it cannot be ruled out that some of the lifestyle characteristics noted on the 
RVCT were suspected/witnessed and then verified by the TB nurse. By this, I mean that a 
patient may have denied drug abuse when questioned directly by the nurse, but over the course 
of several visits, the nurse may have suspected this behavior and corrected the information in 
the patient’s medical chart as well as the accompanying RVCT (which was part of the patient’s 
medical chart). The extent to which “correction” of self-reported data was or was not a 
systematic practice by TB nurses cannot be determined. Thus lifestyle factors, such as drug 
abuse, were assumed to be a sensitive question of self-report. Another lifestyle factor that 
would have been self-reported by the patient was alcohol abuse. However, the TB nurse would 
have taken special care to verify the accuracy of this answer because alcohol consumption (and 
especially abuse) is a contraindication to some TB treatment. Consequently, the accuracy of 
the alcohol abuse question in this data set was expected to be high.  
 The second assumption was that the reliability and validity of the RVCT were 
high; however, the literature review did not find any research that directly measured the 
reliability or validity of the RVCT. This is discussed more in Chapter 3, Methodology. 
 Thirdly, that only active TB cases were counted in TB prevalence. People with 
latent tuberculosis infection (LTBI) are not symptomatic, not contagious, and not 
counted in TB disease prevalence rates. When they reactivate, they become active TB 
cases and thus would be more likely to be detected by the South Carolina TB control 
program, as they would manifest clinically diagnosable symptoms. Asymptomatic 
contacts with positive skin tests that were treated to prevent progression to TB disease 
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did not meet the CDC case definition for an incident or prevalent TB case. This was a 
valid assumption and is true for most TB prevalence studies. 
Limitations 
 This section will discuss the limitations of this study. The first limitation of this 
study was that it is limited to those confirmed TB cases for which a valid TB genotype 
could be obtained. There are two reasons a confirmed case may not have a valid TB 
genotype. The first reason is when a TB case is confirmed without the benefit of a TB 
positive culture (recall that a genotype cannot be performed without a TB cultured isolate 
to perform it on). This is true for all cases that are exclusively extrapulmonary (TB cases 
that have only extrapulmonary disease rather than both pulmonary and extrapulmonary 
disease) because these cases are typically confirmed via some other testing methodology, 
such as a PCR. This is true with the exception of extrapulmonary cases that are of the 
pleural space of the lungs, which are usually confirmed, similar to pulmonary cases, using 
sputum specimens. In fact, for all practical purposes are epidemiologically similar to 
pulmonary TB. Thus, extrapulmonary cases of the pleural space were considered eligible 
cases for genotype in the research sample as well as contagious cases that have contributed 
to the chain of transmission in the community. Confirmed cases that may also not have a 
TB culture are those pulmonary/pleural cases that are confirmed by some combination of 
symptoms and testing other than a positive sputum culture. There are a few reasons why a 
person with true TB pulmonary/pleural disease may not have had an M. tuberculosis 
organism collected and/or isolated. These include, but are not limited to, (a) the patient 
being lost to follow-up, thus no specimen was collected; (b) the patient received partial 
25 
 
 
antibiotic treatment and thus had no viable organism in the specimen; (c) poor specimen 
collection in that the specimen that is collected is not sputum from the lung but was 
shallow esophageal mucous or saliva where little to no organism was present; and (d) poor 
specimen shipping or transfer procedures resulting in viable organism expiring before it 
could be cultured and identified; and (e) the patient being between the ages of 5 and 12 
years when a sputum specimen is not only difficult to obtain but is  also difficult to isolate, 
thus alternative testing is often used to confirm these cases.  
 The second reason a confirmed case may not have a valid TB genotype was 
because all TB isolates are not being genotyped. Ideally, all South Carolina TB diagnosing 
laboratorians would send all their TB isolates to the National TB genotyping lab in 
Michigan for genotyping. The goal for all states participating in the National CDC 
Genotyping Surveillance program (of which South Carolina is one) in 2014 was 90% 
participation and the goal for 2020 is 100% participation. However, South Carolina has 
been falling well short of this goal. From 2005 to 2011, there were 1,346 confirmed cases 
of TB in South Carolina. Of those, 1,080 were pulmonary/pleural only or both 
pulmonary/pleural and extrapulmonary, thus 1,080 were eligible to be diagnosed by a 
sputum culture. A valid genotype was available for only 685 (63%) of those cases.  
 In summary, the missing 37% of confirmed TB cases was a combination of four 
possibilities: Either  
 A culture was not obtained (as mentioned above, this happened frequently in 
children, and occasionally patients were lost to follow-up). 
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 M. tuberculosis was not isolated (again, this happens more frequently in 
children and may happen if a patient has received partial antibiotic treatment). 
 The isolate was not sent for genotyping (the South Carolina lab did not follow 
protocol). 
or  
 The isolate was not able to be successfully genotyped.  
 Unfortunately, in my study sample I had no way of knowing what reason or 
combination of reasons a confirmed TB case patient may not have had a successful isolate 
and/or genotype. In the dataset I was provided by South Carolina DHEC, I had covariate 
information for all the TB cases for which I also had a valid genotype. I had no way of 
knowing in what ways those 420 (37%) incident TB cases without a valid genotype 
differed from the 685 incident TB cases for which I did have a valid genotype. There was 
no reason to believe these 685 cases were randomly selected for genotyping. This may 
have introduced some bias into the estimate of recently acquired infection and in the 
determination of risk factors for genotype clustering. To mitigate this limitation I used 
publically available descriptive data on the TB incident case population of South Carolina 
from 2005 to 2011 to compare with the fully genotyped sample on the covariates of 
interest. These demographic variables were available through an intranet query site called 
the CDC’s Online Tuberculosis Information System (OTIS) that provides data in 5-year 
summary totals by state (CDC, 2016). The information from this site allowed me to 
determine how alike or different my sample was from the entire sampling frame, and to 
qualify my conclusions appropriately.  
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 In addition, this limitation also represented an opportunity. The opportunity to 
emphasize the importance of comprehensive TB case genotyping, to characterize the 
molecular epidemiology of TB in any jurisdiction or geography. This limitation and its 
implications are further discussed in the recommendations section of Chapter 5. 
 A second limitation of this study was that any contribution that unconfirmed 
symptomatic cases could play in the TB chain of transmission, and how this affected 
my estimate of recent transmission, was unknown. Because some symptomatic 
undiagnosed cases (those who never seek medical care and are under the health 
department’s radar) will contribute to the chain of transmission, how these cases may or 
may not differ with the study population regarding the independent variables of interest 
cannot be explored. Therefore, any bias this introduced cannot be examined. However, 
even the most robust TB control programs will miss cases. Again, how these cases 
differ from the cases that are detected by public health surveillance systems are not 
entirely clear. These cases may be more likely to be transient, underserved by the 
healthcare community, possibly undocumented immigrants, or cases of subclinical 
manifestation. This is a limitation for most TB genotyping prediction studies.  
 This third limitation of this study was that it was limited in place and time, in 
that I was only able to examine genotypes of cases diagnosed within South Carolina 
between 2005 and 2011. Cases diagnosed outside of this time period (either before or 
after) within South Carolina; cases diagnosed within this time period but outside of 
South Carolina; and cases diagnosed outside this time period (either before or after) and 
outside of South Carolina, were not included in this study. Therefore, TB chains of 
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transmission beyond the geographic and time boundaries set in this study were not 
investigated. Certainly, this is a common limitation of all molecular epidemiological 
studies, because researchers will always be limited by the data they collect or, as in the 
case of this study, that which is secondarily available to them. However, because TB 
transmission recognizes no time or state boundaries, this has implications for the 
conclusions that may be drawn from this study’s findings. They are explored in Chapter 
5, Conclusions, of this research.  
 The fourth limitation of this study was that while it was a population-based study, 
it represented only individuals living in South Carolina. The fact that the study was 
confined to South Carolina has implications for the generalizability of the study results. 
While South Carolina has a growing urban population, a few modest-sized airports with 
some international flights (such as to Canada and Mexico), and some public 
transportation, it is somewhat behind many other states with regard to these factors, 
especially those in the U.S. northeast. Thus, South Carolina may not be comparable to 
U.S. urban northeast in terms of variety of TB, the presence of drug-resistance TB, and 
conditions of urban overcrowding that may increase risk of transmission for TB.  Using 
public transportation and living among concentrated urban populations have been 
shown to be risk factors for TB infection (Weis, 2002; Friske, 2011; Kirenga, 2015). 
Further, South Carolina has few direct commercial flights from some of the highest TB 
incidence regions, such as Africa and Indonesia. For these reasons, this study may not 
be entirely comparable to U.S. states with (a) more concentrated urban populations, (b) 
expansive, highly used public transportation systems, and (c) large international 
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airports,  because  these three factors are likely to influence the amount and variation of 
TB genotypes and clustering. 
 A fifth limitation of this study was that, for the purposes of answering Research 
Question 1(b), what proportion of TB in South Carolina may be due to recent 
transmission?, epidemiological information (dates of onset, diagnoses, etc.) was not be 
reviewed. This determination was a simple mathematical calculation that provided a 
reasonable indication of the proportion of South Carolina TB cases that  could  be due to 
recent transmission. It was beyond the scope of this study to carry out an in-depth review 
of source medical records to determine the true source for comparison to the 
mathematically calculated determination. First, because the time it takes latent TB 
infection (LTBI) to manifest as disease varies widely because it is often a result of both 
known and unknown host factors. The dates of onset and diagnosis obtained may not be 
helpful or reliable in determing source or index cases for clusters or outbreaks. Second, 
most TB population-based molecular epidemiological studies do not use medial record 
review to determine the proportion of recent transmission, but do it mathematically in just 
the way I have outlined in Research Question 1(b). This was an acceptible limitation 
because the methods used in this study were consistent with previous research and my 
research is directly comparable to other studies of this nature.  
Significance of the Study 
 One of five priority actions that the World Health Organization (WHO) has 
outlined as necessary to accelerate progress towards the 2020 Global Tuberculosis targets 
is to reach the missed cases. From a global perspective, about 3 million people who 
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developed TB in 2012 were missed by national notification systems (WHO, 2013). As 
part of the positive social change implications of this research, it is my hope that cases 
that would have been missed when investigated with traditional contact investigation 
alone will be discovered when employing targeted contact investigation informed by the 
findings of this study. Genotyping may facilitate quicker confirmation of known contacts, 
detection of unknown contacts, or revelation of transmission environments (Malakmadze, 
2006, Yeo, 2006). If a jurisdiction participates in the U.S. national TB genotyping 
program, consistently sends in all its confirmed case specimens for genotyping, and then 
checks those results frequently, they may find linked cases that their standard contact 
investigations did not reveal. In addition, TB contact tracers may confirm suspected 
epidemiological links they were already investigating. This approach may help a 
jurisdiction make decisions about how aggressive and widespread their contact 
investigations should or should not be, where to focus limited resources, and whether 
there are transmission environments that  traditional contact investigations are missing. 
This has been exemplified by clustering studies that have elucidated risk factors that 
serve TB prevention efforts by informing TB control programs where to target limited 
resources (Miller, 2002; Suffys, 1997).  
 Furthermore, this study has two long-term implications. First, these findings may 
lead to better TB control efforts and thus interrupt the chain of transmission yield fewer 
TB infections. This would bring the U.S. one-step closer to TB elimination. Second, 
targeted contact-investigation informed by TB genotype results may yield an overall cost-
savings to the South Carolina TB Control Program and similar programs. 
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Summary 
TB is a current and immediate public health threat of worldwide importance. The 
DTBE at the CDC has, as its long-term goal, the elimination of TB in the US. To this 
end, my research examined factors that significantly contribute to being a part of an 
identical TB genotype cluster in South Carolina between the years 2005 and 2011. As 
part of the positive social change implications of this research it is my hope that cases 
that would have been missed when investigated with traditional contact investigation 
alone, will be discovered when employing targeted contact investigation informed by the 
findings of this study. Furthermore, the long-term implications of this study may lead to 
better TB control efforts with targeted contact investigation that results in an overall cost-
savings to the South Carolina TB Control Program and similar programs.  
Chapter 2 will provide an in-depth discussion of the research on U.S. and 
European populations with low incidence of TB that is similar to my study population. 
Chapter 2 will also provide a framework for this research and describe the gap in the 
literature that my research fills. 
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Chapter 2: Literature Review 
Introduction  
This research examined (a) what proportion of South Carolina TB cases from 
2005 to 2011 were due to recent transmission and (b) the risk factors among incident 
cases that were significantly associated with being part of an identical TB genotype 
cluster of two or more cases. The goal of providing additional clarity to South Carolina 
TB transmission dynamics, and useful information to the South Carolina TB Control 
Program. To frame this research and identify gaps in the literature, I reviewed applicable 
studies on TB genotyping and the predictors for clustering in relevant populations. While 
there have been population-based studies examining predictors for clustering in the U.S. and 
other developed countries as well as the developing world, I found a paucity of studies in the 
southeast U.S.. This reflected an important gap in the literature. The southeast U.S. remains 
an area of high TB incidence, particularly among Black people.  In the southern states, 
TB is almost exclusively transmitted in relatively insular networks defined by race, 
ethnicity, and SES (Moonan, 2012; Kempf, 2005). The reasons for this are not clear, but 
in general, southern states provide less Medicaid funding per person; there is less funding 
for infectious disease control and intervention; and there is less direct state funding to 
public health departments (Salinsky, 2010; Reif, 2012; DHHS, 2013). Further, remnant 
and non-traditional segregation may also play a role in this racial disparity for what is a 
highly infectious disease transmitted person-to-person. These concerning questions 
indicated a need for continued research. Certainly, the number of individuals suffering 
from, or at risk of, TB in the developing world—as well in the crowded urban areas of the 
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developed world of the US, Canada, and Europe—has prompted some important TB 
genotyping studies in these geographic regions (Verner, 2004; Moonan, 2012; Hernandez-
Garduno 2002; Kamper-Jørgensen, 2012,). However, this review was limited to those studies 
that examined predictors for clustering in populations that were similar to my study 
population, such as those in other industrialized countries that could be expected to have 
similar TB incidence as the US. 
The review begins with an overview of the search strategy. I then discuss the 
history of tuberculosis. The first part of the review discusses the conceptual framework 
behind tuberculosis genotyping. I then discuss the rationale for in the chosen statistical 
analysis methods. Following that, I review the literature related to each of the covariates 
I examined in my study. Finally, I discuss a review table of the various rates of 
clustering and recent tuberculosis transmission observed in prior population-based 
genotype clustering studies. 
Literature Search Strategy 
In this literature search, the following databases were used: CINAHL, Medline, 
Health Sciences, ProQuest Health and Medical Complete, Ovid Nursing Journals, and 
PubMed. I limited the searches to peer-reviewed journals published within the last 12 
years. (Seminal research older than 12 years was also reviewed to provide historical 
context.) In all searches, I used the following keywords or phrases: tuberculosis genotype 
clusters, tuberculosis genotyping, tuberculosis clusters, molecular surveillance of 
tuberculosis, molecular epidemiology of tuberculosis, and DNA fingerprinting of 
tuberculosis. 
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Tuberculosis Background 
The causative agent of most human TB disease is an aerobic bacterium that was 
discovered by Robert Koch in 1892, and later named Mycobacterium tuberculosis. The M. 
tuberculosis complex (MTBC) includes four other TB-causing mycobacteria: M. bovis, M. 
africanum, M. canetti, and M. microti. M. africanum is not widespread, but it is a 
significant cause of tuberculosis in parts of Africa. M. bovis was once a common cause of 
tuberculosis, but the introduction of pasteurized milk has largely eliminated this as a 
public health problem in developed countries. M. canetti is rare and seems to be limited to 
the Horn of Africa, although a few cases have been seen in African emigrants. M. microti 
is also rare and is mostly seen in immunocompromised people (CDC, 2011).  Historical 
research indicates that by the time the causative agent was discovered every seventh 
person in the world was likely already infected (Santic, 2013). The source of infection is 
typically a person symptomatic with pulmonary, laryngeal or bronchial TB that then 
transmits by infectious droplets to their close contacts. The most infectious person is 
someone who in 1 milliliter (ml) of sputum will excrete around 10,000 TB germs, and this 
sputum will be TB positive on microscopic tests. Because TB is acquired through airborne 
transmission of droplet nuclei risk of infection has been shown to increase with nuclei 
concentration in droplets and with time of exposure to these nuclei (Bass, 1990). Once an 
individual has been infected, s/he remains infected for a long time, possibly progressing to 
active disease, sometimes years after the initial infection. In healthy people, about 10% of 
infected cases will progress to active disease. Conditions such as immunosuppression with 
HIV, physical and emotional stress, and very young age all substantially increase risk for 
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developing active disease after primary infection, the risk being highest among young 
children. Development of TB disease may be due to reactivation of latent disease or to 
reinfection. Effective treatment for TB was not developed until 1944 when streptomycin 
was first used. This was later followed by isoniazid and rifamycin regimens, which 
significantly increased the TB cure rate to as much as 95% (Suffys, 1997).  
 Most TB infection is concentrated in the lungs; however, extrapulmonary 
tuberculosis is TB disease where infection has spread outside the lungs. This may include 
the pleural space, the central nervous system, the genitourinary system, the lymphatic 
system or the skeletal system. It may be more difficult to diagnose and treat. It is more 
common in HIV-infected patients because it is related to the failure of the immune 
response to contain M. tuberculosis, thereby enabling haematogenous dissemination and 
subsequent involvement of single or multiple nonpulmonary sites (Lee, 2015). The 
organism proliferates and disseminates throughout the body (“miliary” tuberculosis). 
Cough may not be a typical symptom as the initial pulmonary infection may have passed 
by this point. Symptoms of extrapulmonary TB are vague and include fever, weight loss, 
night sweats, anorexia, and weakness. Extrapulmonary TB is much more common in the 
developing world where no treatment, inadequate treatment, and treatment failure are 
more common than in the U.S. (Lee, 2015). 
Conceptual Framework 
 Because prompt identification of TB patients through symptom screening and 
testing, along with evaluation of contacts, can be difficult in hard-to-reach populations, 
thorough identification of TB contacts is more important than ever to achieving the 
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national goal of TB elimination (Dade County Cluster, MMWR 2012). Genotyping may 
facilitate quicker confirmation of known contacts, detection of unknown contacts, or 
revelation of transmission environments (Malakmadze, 2006; Yeo, 2006). If a 
jurisdiction participates in the U.S. national TB program, consistently sends all their 
confirmed case specimens in for genotyping, and checks those results frequently they 
may find linked cases their standard contact investigations did not reveal. In addition, 
TB contact tracers may confirm suspected epidemiological links they were already 
investigating. Importantly, this approach may help a jurisdiction make decisions about 
how aggressive and widespread their contact investigations should or should not be, 
where to focus limited resources, and if there are transmission environments their 
traditional contact investigations are missing. This has been exemplified by clustering 
studies that have elucidated risk factors, which serve TB prevention efforts by 
informing TB control programs where to target limited resources (Miller, 2002; Suffys, 
1997). Because the U.S. national TB genotype coverage (i.e. the proportion of 
confirmed cases that are successfully genotyped) has increased from 51.2% in 2004 to 
88.2% in 2010 (MMWR, 36, 2012), this has greatly expanded genotyping’s value in 
characterizing populations at high risk for TB transmission and outbreaks.  
 The primary concept applied in this study is commonly referred to as 
tuberculosis genotyping. Most simply defined, TB genotyping is the laboratory-based 
genetic analysis of the bacteria that cause TB disease, and when combined with 
epidemiological data has sufficient discriminatory power to help find TB cases likely to 
be in the same chain of transmission, or determine that cases are not in the same chain 
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of transmission. There are three primary methods for genotyping TB isolates: IS-6110-
based genotyping also known as restriction fragment length polymorphism (RFLP) 
technique, MIRU-based genotyping, and spacer oligonucleotide typing also known as 
spoligotyping-based genotyping. For this review, I will focus on MIRU-based 
genotyping and Spoligotyping because those are the methods that were used in this 
study. However, in this section, I will provide a brief discussion of RFLP technique as it 
was used in some of the studies I will reference and it was a groundbreaking method for 
genotyping.  
 One of the first methods for TB genotyping developed in the early 1990s was 
RFLP technique, and it has been used extensively for TB genotyping and 
epidemiological studies since that time. There is a substantial amount of research 
indicating the accuracy of RFLP in determining TB genotype matches (Samper, 1998; 
Barnes, 2003; Ellis, 2002; Love, 2008). It is the standard approach for the analysis of the 
distribution of the insertion sequence IS6110 in different strains. Its basis is that isolates 
from patients infected with epidemiologically unrelated strains of tuberculosis have 
different RFLP patterns, or different distribution sequences of IS6110, whereas those 
from patients with epidemiologically linked strains generally have identical RFLP 
patterns. While it is a highly discriminatory method, it is also complex and time 
consuming, as it requires sub-culturing isolates for several weeks to obtain sufficient 
DNA for typing. Currently, large databases of IS6110-based genotypes are available for 
TB control programs and researchers to review and use to compare strains. Because 
strains with fewer than six IS6110 insertion sites have a limited degree of 
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polymorphism, a supplementary method of genotyping may be required in this 
circumstance, such as spoligotyping. 
 Spoligotyping was developed somewhat concurrently with RFLP and has been 
used successfully in TB research for determining DNA patterns of M. tuberculosis 
isolates (Barnes, 2003; Kempf, 2005). The direct-repeat locus in M. tuberculosis 
contains 10 to 50 copies of a 36-bp direct repeat, which are separated from one another 
by spacers that have different sequences. However, the spacer sequences between any 
two specific direct repeats are conserved among strains. Because strains differ in terms 
of the presence or absence of specific spacers, the pattern of spacers in a strain can be 
used for genotyping. Spoligotyping has two advantages over RFLP. First, because only 
small amounts of DNA are required, it can be performed on clinical samples or on 
strains of M. tuberculosis shortly after their inoculation into liquid culture and thus it 
has a faster turn-around time. Second, the results of spoligotyping are expressed as 
positive or negative for each spacer thus they can be reported in a digital format (like 
the results of MIRU analysis noted below) facilitating the creation of large web-based 
databases. The primary limitation of spoligotyping is that it is less discriminatory than 
either RFLP or MIRU. However, when used in conjunction with MIRU, as it was in my 
study population, it has excellent matching power (Barnes, 2003). 
 A third method is MIRU-based genotyping. The genome of M. tuberculosis 
contains many MIRUs, some having identical repeat units and others having repeats 
that differ slightly in sequence and length. MIRU genotyping describes the number and 
size of the repeats using a polymerase-chain-reaction (PCR) assay, followed by gel 
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electrophoresis. The discriminatory power of MIRU genotyping is nearly as good as 
that of RFLP but unlike RFLP, MIRU analysis can be automated and many strains 
typed simultaneously, yielding results that can be digitally catalogued in a web-based 
database. MIRU is technically simpler than RFLP and can be applied directly to M. 
tuberculosis cultures without DNA purification first, thus resulting in a quicker turn-
around. Because of the quicker turn-around of both the spoliogotyping and MIRU 
methods, these are better for use in ongoing contact investigations than compared with 
the RFLP method. 
 There is a substantial amount of research indicating the applicability of TB 
genotyping in TB epidemiological investigations, especially in low to moderate incident 
countries (Samper, 1998; Barnes, 2003; Ellis, 2002; Kempf, 2005,; Malakmadze, 2005; 
Love, 2008). For example, in a U.S. study Malakmadze and co-investigators revealed 
three clusters of 19 patients by matching patient isolates with all three methods: RFLP, 
MIRU, and spoligotyping. Then researchers retrospectively performed medical record 
reviews and patient interviews, which revealed that most of these clustered patients had 
no obvious epidemiologic links, but the medical records did point to several previously 
unrecognized locations of possible TB transmission. These unrecognized locations of 
transmission were a single-room occupancy hotel, two homeless shelters, one bar, and 
two crack houses. This study perfectly illustrates that transmission of TB among high-
risk groups may go undetected for years when relying on patient recall alone. This is 
because it is very difficult to obtain a complete contact list from persons with often 
numerous and frequent transient living and socializing environments coupled with 
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alcohol and drug abuse behaviors. In addition, this investigation particularly highlights 
the value of using multiple methods for TB genotyping to confirm genotype matches, 
and reveal previously unrecognized locations of transmission that may be targeted for 
specific TB interventions (Malakmadze, 2005).  
Statistical Analysis in the Literature 
After a thorough review of population-based studies that have examined the 
association of various risk factors for clustering, I found that most studies consistently 
employ logistic regression to model this relationship. For the remainder of this chapter, 
all correlational studies reviewed should be assumed to have used this technique unless 
otherwise noted. Further, logistic regression was used as my primary data analysis 
technique for Research Questions 2. Logistic regression was an appropriate choice 
because it is a powerful and reliable statistical too and has been used for many decades in 
health science research (Kleinbaum, 1988; Hosmer, 1989). The nature of these research 
questions and the extensive use of logistic regression in the current literature to determine 
the impact of independent variables have on the dependent variable indicate it was the 
best option. Parsimonious model building via backward elimination of insignificant 
covariates was applied when calculating adjusted odd ratios (aOR). Odds ratios >1.0 with an 
associated p-value <0.05 were interpreted as a risk factor for clustering. Likewise odds ratios 
<1.0 with an associated p-value <0.05 were interpreted as protective for clustering. Further 
details regarding the statistical methodology used in my study are provided in Chapter 3.  
Literature Review Related to Key Variables 
 Numerous studies have evaluated various demographic, social, and clinical 
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factors on risk for clustering versus singleton, where singleton is defined as a TB case 
that does not belong to a known genotype cluster (Love, 2009; Barnes, 1997; Cacho-
Calvo, 2005; Cattamanche, 2006; Fok, 2008; Kempf, 2005; Chan-Yeung, 2006; Driver, 
2006; Ellis, 2002). The body of literature that precedes my research used both first and 
second-hand data collection from a variety of sources including, but not limited to: the 
RVCT exclusively, the RVCT supplemented by retrospective medical record review, 
first-hand comprehensive medical record review, first-person patient interviews and 
medical record review, interviewer-administered questionnaires, or patient self-
completed questionnaires. For this reason, the studies discussed in this literature review 
represent a wide range of covariates that have been collected and examined in relation 
to clustering. As with any research, my research was limited to evaluating only those 
factors (i.e. covariates) for which my secondary data set contains complete and reliable 
information. To those ends, the scope of this literature review and the list of covariates 
below is limited to only those that examined in my research.  
 Two seminal studies worth highlighting are that of Fok’s 2008 meta-analysis on 
36 population-based TB genotyping studies and Moonan’s 2012 US-wide 
comprehensive genotyping and geospatial scanning estimate study. Both are referred to 
multiple times in this chapter. Fok’s study is important because of its comprehensive 
meta-analysis of prior research (Fok, 2008). Moonan’s study is important because it 
examined all TB cases in the U.S. that had a genotyping result from 2005 to 2009, and 
employed a geospatial scanning strategy to determine if matching genotype cases were 
likely to be a result of recent transmission (Moonan, 2012.) 
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 Fok’s meta-analysis (which does not include any studies after 2007) found that 
in countries with low TB incidence the characteristics of local birth, male sex, minority 
race, substance abuse (alcohol abuse and injection drug use), and homelessness were 
associated with TB clustering and recent TB transmission (a finding consistent with 
other published studies). Similarly, in the US, Moonan found that the characteristics of 
persons U.S. born, being male, members of a minority race or ethnic group, persons that 
abuse substances and the homeless are at higher risk for TB clustering and recent 
transmission, again a finding that is consistent with other U.S. studies.  
 Below, I have listed each covariate I examined in my study and a brief 
description of what the body of literature has found in relation to clustering. Each 
covariate is listed by the term I will use to refer to it for the remainder of this 
dissertation. In parentheses beside the covariate is the category/alternative of that 
covariate that previous research has usually observed (but not always) to be positively 
predictive for clustering. Generally, studies have grouped covariates into the broad 
categories of (1) demographic (2) social and (3) clinical. There may be some overlap 
between categories, but I have taken care to group each of my covariates similarly. 
Demographic 
 
 Country of Birth (Not Being Foreign-Born). For studies conducted in the U.S., 
U.S. natives are more likely to be part of genotype clusters than those of foreign birth. 
This has also been observed in European studies, such that persons native to the country 
of study origin are more likely to be part of a genotype cluster than those of foreign 
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birth. For example, researchers conducting a study in the Netherlands found native-born 
Danes at higher risk for clustering compared to those of foreign birth, and researchers 
conducting a study in Italy find those native to Italy at higher risk for clustering than 
immigrants (van Soolingen, 1999 & Moro, 2002, respectively).  
 A Massachusetts study by Miller and colleagues found an adjusted odds ratio 
(aOR) of 2.29 (95% C.I. 1.69-3.12) for the association of clustering among U.S. born when 
compared to foreign-born persons (2002). Additionally, Moonan’s a population-based study 
(including all genotyped cases of TB reported to the U.S. National Tuberculosis 
Surveillance System (NTSS) by the 50 states and the District of Columbia) observed an 
aOR of 2.4 (99% C. I. 2.1-2.7) between clustering and U.S. birth (2012). In Denmark, 
Kamper-Jorgensen and co-authors found that TB cases in large clusters (≥ 0) were 7.7 (3.6 
-16.4) times more likely to be Danish born than non-clustered TB cases (2012). 
Similarly, in a study from the Netherlands, van Soolingen and colleagues observed that not 
being Dutch-born was protective for clustering in both Mediterranean and African-born 
residents with aORs of 0.7 (95% C.I. 0.6-0.8) and 0.7 (0.6-0.9), respectively. They also 
found that longer periods of residence in the Netherlands (> 2 years) was a risk factor for 
clustering with an aOR of 1.4 (95% C.I. 1.1-1.8) (van Soolingan, 1999). In Italy (among 
non-AIDS patients), the aOR was 1.44 (95% C.I. 1.08-1.92) for the association of native-
born Italian nationality and clustering (Moro, 2002).  
 The reasons for this association are somewhat intuitive. First, persons born in 
countries with high TB incidence are more likely to have acquired TB in their country of 
origin prior to arriving to U.S. or Europe, as Western countries have comparatively low 
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incidence. Thus, foreign-born persons may be more likely to have a singleton genotype if 
their TB is diagnosed early after arrival. Second, native-born persons would likely have had 
more time within their native country to have acquired and spread TB to their contacts, than 
recently arrived immigrants. Essentially, foreign-born persons are more likely to have 
acquired their TB natively within a genotype cluster in their country of origin and may or 
may not propagate that cluster once they immigrate. 
 Age (younger). Most studies have found that younger age is a strong, independent 
predictor of clustering. How age is categorized and the reference group varies by study, but 
generally studies have observed that younger cases are more likely to be clustered while 
older cases are less likely to be clustered (Kamper-Jorgensen, 2012; Zolnir-Dovc, 2003; 
Barnes, 1997; Talarico, 2012; Moonan, 2012). In the Moonan population-based U.S. 
study (that included all genotyped cases in the 50 states and DC from 2005-2009), when 
investigators used 25-44 years as the reference age group they found that age 0-4 years 
were positively associated with clustering (aOR = 3.1; 99% CI. 1.4-6.8) and >= 65 
years was protective for clustering (aOR = 0.5; 99% C.I. 0.4-0.6) (Moonan, 2012). 
Further, in an early study from central Los Angeles, Barnes and colleagues observed a 
similar finding with an aOR of 4.1 (99% C.I. 1.1-15.1) associated with younger age 
(1997). Another study from Arkansas found that among TB cases <65 years old 56.4 % 
were clustered versus those >= 65 years old 43.6% non-clustered with p-value <0.0001 
(Talarico, 2012). European studies have observed comparable results. In Slovenia, 
investigators observed that clustering rate decreased as age increased from 46.4% (age 
group under 35 years) to 19.5% (age group above 65 years) yielding an aOR of 0.42 
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(95% C.I. 0.74-2.21) (Zolnir-Dovc, 2003). Maguire and colleagues observed a marked 
dose response relationship with age and clustering in Londoners from 1995 to 1997. 
When using 60 years of age and older as the reference group, authors observed those 0-
19 years at the highest risk of clustering with an aOR of 2.65 (95% C.I. 1.59-4.44), 
those 20 to 34 at the second highest risk with an aOR of 1.51 (95% C.I. 1.02-2.22) and 
those 35-59 at the third highest risk with aOR 1.43 (95% C.I. 0.97-2.11).  
 The reason for the association of younger age and clustering may be that older cases 
are more likely the result of reactivation of latent infection. In addition, it is important to 
keep in mind that genotype studies must examine clustering over a limited period. Thus, 
while older persons might be part of clusters, the ability of studies to detect clusters in 
excess of their review period would be limited, and certainly, the use of the genotyping 
in general to detect clusters originating 20 to 40 years ago would not be possible as the 
technology did not exist. In summary, older people have had more cumulative time to 
have been infected with TB and for this reason their disease is more likely to be the 
result of reactivation than their younger counterparts; meaning the odds of infection 
having been acquired before study initiation, outbreak detection, or cluster propagation 
are greater in older persons than in that of younger persons.  
 Sex (male). For all studies where a sex association was observed, male sex was 
independently associated with being part of a TB genotype cluster. While not all studies 
have observed an association with sex and clustering (Franzetti, 2009; Driver, 2006; 
Maguire, 2003; Cacho-Calvo, 2005). However, no studies (to date) have observed a 
significant positive association between clustering and being female. The US-wide study 
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by Moonan and colleagues (referred to earlier) found that men were 1.2 (95% C.I. 1.1-
1.3) times more likely to be clustered than women. In an ethnically diverse region of 
southern California, Rodwell and co-authors observed an aOR of 1.57 (95% C.I. 1.17-
2.10) for men and clustering. Similarly, in Arkansas, Talarico and co-investigators 
found that 48.2% of men were clustered versus only 28.0% of women with a p-value of 
0.058 (2012). In Kamper-Jorgensen’s study from Denmark investigators observed that, 
men were 2.5 times more likely to be clustered than women (2012).  Results are similar in 
direction and magnitude in the Ellis U.S. study of 7 sentinel surveillance sites, the 
Driver study of New York City, and the van Soolingen study in the Netherlands (2002, 
2006, and 1999, respectively).  
 The reasons males are at higher risk for clustering are not entirely understood 
but probably work in concert with many of the same reasons men are at greater risk for 
TB in general, including increased rate and effect of alcoholism, increased rate of 
incarceration, more homelessness, more use of homeless shelters, greater delays in 
seeking treatment, and possibly more social/congregate alcohol and drug abuse 
behavior (Oeltmann, 2009).While most studies do control for some of these factors, no 
one study or combination of studies could be expected to entirely control for these 
complex social and clinical factors.  
 Race (Black). U.S. studies have consistently found that black race is a strong 
independent predictor for being part of a TB genotype cluster. Most U.S. studies use non-
Hispanic white as a reference group when examining this association. In Moonan and co-
authors’ study that included all genotyped cases in the U.S. from 2005 to 2009, 
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investigators observed the following associations with clustering: an aOR of 2.4 (99% 
C.I 2.2–2.7) for black, non-Hispanic; an aOR of 1.7 (99% CI 1.5–2.0) for 
Hispanic/Latino; an aOR of 2.6 (99% C.I. 1.5–4.4) for native Hawaiian/Pacific Islander; 
and an aOR of 1.5 (99% C.I. 1.3-1.8), when using non-Hispanic white as the reference 
group. Talarico and co-authors observed similar results in an Arkansas cohort from 1996-
2003 finding an aOR of 2.07 (95% C.I. 1.52-2.82) for non-Hispanic blacks and clustering 
when compared to non-Hispanic whites (2011). Likewise results were similar in Texas 
where Serpa observed TB cases clustered in 82% and 77% of blacks and whites, respectively 
(p = 0.46) and additionally that cluster size was significantly larger in U.S. born blacks than 
whites (p  < 0.001) (2009).  
 Ethnicity (Hispanic/Latino). The association between being Hispanic/Latino and 
clustering is not as clear as that of black race. A very early study from San Francisco found in 
patients under 60 years of age being Hispanic to be a greater predictor (OR = 3.3,  p-value = 
0.02) for clustering than being black (OR = 2.3,  p-value = 0.02) (Small, 1994). While one 
important comprehensive U.S. study observed Hispanic/Latino a statistically significant 
positive predictor for clustering, although less in magnitude than black race, that of Moonan 
noted above. A few studies have suggested a protective relationship with being 
Hispanic/Latino and clustering (Ellis, 2002; Weis, 2002). 
Social 
 Homelessness (current, or within prior 12 months). Some studies have found that 
being homeless in the year prior to TB diagnosis is a strong independent predictor for being 
part of a TB genotype cluster (Moonan, 2012; Zolnir-Dovc, 2003; Ellis, 2002; Love 2009; 
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Barnes, 1997; Driver, 2006; Rodwell, 2012). While not all studies that examined recent 
homelessness as a potential predictor for clustering have observed a statistically significant 
association (Moro, 2002; Diel, 2002), none have observed a protective association. In all 
U.S. genotyped cases from 2005-2009, Moonan and co-authors observed that being 
homeless within the last 12 months was significantly associated with clustering with an 
aOR of 1.4 (99% C.I. 1.2-1.6) (2012). In an ethnically diverse region of southern 
California, Rodwell and colleagues found an aOR of 3.44 (95% CI 1.65-7.18) for 
homelessness (2012). In Slovenia, Zolnir-Dovc and colleagues also observed that a 
history of homelessness was significantly associated with clustering with an aOR of 
5.73 (95% C.I. 1.21-27.13) (2003). In England, Love and co-authors found an aOR of 
5.5 (95% C.I. 1.2-24.1) for homelessness and clustering (2009).  
 The reasons postulated for homeless persons being at greater risk for clustering 
vary but one reason may be that homeless people congregate in environments where TB 
cases and outbreaks often occur such as homeless shelters or homeless ‘camps’ 
(McElroy, 2003; CDC, 2003; CDC, 2005). Additionally, this population may also have 
delay in seeking medical care for diagnosis and treatment resulting in longer periods of 
infectiousness and transmission (Tan de Bibiana, 2011; McAdam, 2009).  
 Homeless Shelter (current, or within prior 12 months). A few studies have 
examined stay in a homeless shelter as a potential predictor, either as a subset of the 
homelessness covariate or separate from homelessness. Similar to homelessness, 
persons with a recent history of stay in a homeless shelter may be at higher risk for 
clustering (Barnes, 1997; Malakmadze, 2005). In Los Angeles, Barnes and co-authors 
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observed that compared with non-clustered patients, patients from clusters were 
significantly more likely to have spent time at 3 shelters and other locations when at 
least 1 patient in the cluster was contagious, and these locations were independent 
predictors for clustering (1997). Barnes also noted that among non-homeless persons, 
clustered patients were significantly more likely than non-clustered patients to have 
used daytime services at any of three shelters (Barnes, 1997). Additionally, in a 
Wisconsin study investigators observed that clustered cases were associated with 
homelessness, residence in homeless shelters and single room occupancy hotels. This 
apparent increased risk for clustering may actually be just better detection. Because 
homeless shelters have been the site of several TB outbreaks in the U.S. (Barnes, 1997; 
McElroy, 2003; CDC, 2003; CDC, 2005), many homeless shelters perform routine 
PPD’s on residents. This intervention may result in better case finding, discovering 
small clusters of two or three persons instead of the singleton cases that might have 
been discovered outside the shelter environment where their genotype match (es) may 
go undetected. 
 Incarceration (current, or within prior 12 months). A couple of studies have 
found that being incarcerated in prison or jail is an independent predictor for clustering 
(Moro, 2002, Kempf, 2005). Kempf and co-authors observed an aOR of 2.9 (95% C.I.1.3- 
6.6) (2005) for the association of clustering and residence in a correctional facility in the year 
prior to diagnosis. In an Italian study Moro and co-authors observed that aOR of 2.03 (95% 
C.I. 1.41-2.92) among non-AIDS patients, but did not observe a significant association 
among AIDS patients (Moro, 2002). Importantly, Moonan’s U.S. wide population-based 
50 
 
 
study (previously cited) did not observe an association with residence in a correctional 
facility at the time of diagnosis (aOR 0.8; 99% C.I. 0.7-1.0) (2012). However, Moonan did 
not examine incarceration within the year prior to diagnosis, only current incarceration. 
 The reasons for this observed association are several. Prisons and jails are locations 
where TB outbreaks occur often, cases go unrecognized, and medical care is suboptimal. 
TB transmission is facilitated by crowding, delay in diagnosis, treatment non-compliance, 
improper isolation; healthy prisoners are mixed with unhealthy prisoners, and questionable 
nutrition (Moro, 2002; Kempf, 2005). This population, especially in jails is transient. In 
jails, PPDs are routinely placed on new inmates, but may never be read. Thus, cases may be 
missed and later diagnosed on the outside. 
 Alcohol (current, or history of abuse.) Several studies have found that alcohol 
abuse is one of the strongest risk factors for clustering. In Arkansas, rates of clustering 
were 19.8% among those with a history of alcohol abuse versus 8.6% among those 
without (p-value < 0.0001) (Talarico, 2011). Also, Ellis and Kempf observed similar 
results among other U.S. populations (2002 & 2005, respectively). Moonan’s 
comprehensive U.S.-wide study, noted earlier, also found a strong association between 
clustering and being more likely to abuse substances with an aOR of 1.4 (99% C.I. 1.3-
1.7), where substance abuse was any abuse of drugs or alcohol (2012). Non-U.S. studies 
have observed similar results. In Londoners, Maguire and co-investigators found that 
alcohol dependence was an independent risk factor for clustering with an aOR of 2.33 
(99% C.I 1.46-3.72). In Slovenia, cases with a history of alcohol abuse were at a 
significantly increased risk for clustering with an aOR of 1.88 (95% C.I. 1.10-3.23). In 
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Germany, alcohol abuse was also strongly associated with clustering (aOR = 5.11, 95% 
C.I. 2.77–9.43) (Diel, 2002). In Fok’s meta-analysis, alcohol abuse was strongly 
associated with clustering in both low TB incidence populations with a pooled 
unadjusted and adjusted OR of 2.2 (95% C. I. 1.6–2.9), and high TB incidence 
populations with a pooled unadjusted and adjusted OR of 1.4 (95% C. 1.1–1.7) (2008). 
 Persons that abuse alcohol may be at greater risk for clustering for a number of 
reasons. They may (1) congregate closely in social settings such as bars (2) have poor 
recall of social contacts and events, thus are not able to provide a comprehensive 
contact list to public health investigators, (2) have unknown, thus uncontrolled for co-
morbidities that increase their vulnerability for disease as well as decrease the time they 
progress from infection to disease, (3) experience delays in diagnosis and treatment, or 
(4) be more prone to treatment non-adherence due to the interaction of alcohol and 
common TB drugs. These four issues may result in alcoholics becoming infectious 
earlier and staying infectious longer more so than non-alcoholics, and then transmitting 
to casual social contacts.  
 Illicit Drugs (current, or history of abuse). Some studies have found that 
abusing illegal/illicit drugs is an independent predictor for clustering (Ellis, 2002; 
Driver, 2006). In the Moonan study mentioned in the alcohol section above, where 
investigators examined a composite variable that combined injection drug use, non-
injection drug use and excessive alcohol abuse into one covariate called substance 
abuse, they observed an aOR of 1.4 (99% C.I. 1.3-1.7) for all substance abuse and 
clustering (2012). In an earlier study that used the same composite definition as the 
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Moonan study and examined all U.S. TB patient genotyped isolates from 2004 to 2005, 
investigators found that among U.S. born patients the odds of involvement in a county-
level genotype cluster were 2.3 (99% C.I. 2.0-2.7) for substance abuser versus a non-
abuser. The odds of involvement in a county level cluster for foreign-born patient were 
less, but still significant at 1.5 (99% C.I. 1.2-2.0) among those who reported substance 
abuse (Oeltmann, 2009). Further, Oetlmann’s study observed that those who abuse 
substances were more likely to have sputum smear positive disease and to experience 
treatment failure (2009). The reasons postulated for this association are comparable to 
those for the association of alcohol abuse and clustering. These may include poor 
contact and social history recall, poor nutrition and other drug abuse related health 
issues resulting in quicker progression from infection to disease, and delayed diagnosis. 
Further, persons who abuse alcohol, crack cocaine, heroin, marijuana, and 
methamphetamines have all been shown to experience significant weakening to one or 
more important immunologic mechanisms (Gamble, 2006; Baldwin, 1997; Lysle, 2000; 
Tashkin, 2002; Friedman, 2003; Mahajan, 2006).  
 In contrast with alcohol abuse, there is the additional issue. Drug addicts often 
use secretly in covert locations, and may be unlikely to reveal these locations or drug-
use contacts to public health investigators due to the illegal nature of this habit. 
Furthermore, often substance abuse occurs in enclosed spaces with intentionally limited 
or poor ventilation and high volumes of human traffic likely increasing the odds of TB 
transmission (Oeltmann, 2006; Oeltmann, 2009). Additionally it has been noted that 
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persons who abuse substances are less likely to seek treatment resulting in an extended 
period of infectiousness and advanced disease at diagnosis (CDC, 2003).  
 Injection Drugs (subset of Illicit Drugs) (current, of history of abuse). Some 
studies were able to stipulate this relationship by examining non-injection drug users 
separately from injection drug users. The results of these studies varied. Kempf and co-
investigators found that clustered patients had a crude OR of 1.9 (95% CI, 1.1 to 3.3), 
among non-injection drug users (2005) but no effect for clustering among infection drug 
users. While Hernandez and co-authors observed that among patients 60 years and 
younger that were injection drug users the aOR for clustering was 3.0 (95% C.I. 1.4 to 
6.7) (2002). Fok’s meta-analysis found that injection drug was associated with 
clustering in the 10 low incidence population-based studies they examined with a 
pooled unadjusted and adjusted OR of 2.9 (95% C.I. 2.0–4.2) (2008). The reasons for 
these inconsistent findings among studies are not entirely clear but may represent a 
difference in the associated drug culture and the high-risk environments among the 
study populations. For instance among European populations, ‘shooting galleries’ may 
be common, where people might congregate and spread disease. On the other hand, this 
may not be as prevalent in the U.S. where there might be less congregating among 
injection drug users. While in the U.S. ‘crack houses’ are places where persons are 
smoking drugs, congregating, and sharing TB germs which might be why Kempf’s U.S. 
study observed an association among non-injection drug users only. Further, studies 
have found that prolonged use of many inhaled or smoked drugs principally crack 
cocaine, leads to increased coughing and other negative pulmonary effects (Leonhardt, 
54 
 
 
1994) which may facilitate the spread of TB. It is worth nothing that to date, most 
studies have not examined the drug abuse and clustering relationship to the granularity 
of injection drug use versus non-injection drug use, but more research is needed. 
Clinical 
 Human Immunodeficiency Virus (HIV) (seropositivity) (AIDS diagnosis). By 
definition, confirmed TB cases that are HIV positive have AIDS because TB is one of 
several conditions that coupled with HIV infection is an AIDS-defining condition. 
Thus, HIV positive TB cases may or may not be aware of their HIV infection before 
their TB diagnosis. However, once a patient tests positive for HIV concurrently with 
their TB diagnosis they actually have three new diagnoses: HIV infection, ‘full-blown’ 
AIDS and TB disease. For this reason, all HIV positive persons in my study population 
were considered AIDS patients and were analyzed as part of an HIV seropositivity 
(inclusive of all HIV and AIDS cases) covariate analysis. Meaning, this analysis did not 
attempt to distinguish those HIV positive persons that may or may not have been 
diagnosed with AIDS prior to their TB diagnosis. Most other studies also assess HIV 
seropositivity in this way and do not perform a subset analysis of AIDS cases or any 
analysis by immune-competence among HIV infected persons.  
 A few U.S. studies have observed HIV seropositivity to be an independent 
predictor for being part of a TB genotype cluster (Ellis, 1994; Talarico, 2011; Moonan, 
2012) while others have found no relationship (Kempf, 2005; Rodwell, 2012). Ellis and co-
investigators observed a relative risk of 1.37 (95% C.I. 1.29% to 1.46%), p-value = 
<0.001 for being HIV positive and clustering (2002). Small and colleagues found in 
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patients under 60 years of age an aOR of 1.8 (p-value = 0.04) for being HIV positive and 
clustering (1994). Talarico and co-investigators in their Arkansas study observed that 
HIV was significantly overrepresented in medium size TB clusters with 4.6% versus 
4.0% (p-value < 0.0001) (2011). In Moonan’s U.S.-wide study investigators observed a 
crude OR of 1.7 (99% C.I. 1.5–1.9) and aOR of 1.1 (99% C.I. 1.0–1.3) for being HIV 
positive and TB clustering (2012).  
 Results of European studies have varied. Moro’s Italian study found that 60.2% 
of AIDS cases were part of a TB cluster (p-value < 0.00001) (Moro, 2002). While 
Franzetti’s study of immigrants residing in Italy found no relationship between HIV status 
and clustering (2010). Also, Samper and colleagues in their Spanish study did not find a 
relationship between HIV status and clustering (1993). Outside of the U.S. and Europe, 
no significant relationship is noticeable between being HIV positive and TB clustering 
particularly in areas with high TB incidence such as Uganda and South Africa (Asiimwe, 
2009 & Verver, 2004, respectively). Some investigators hypothesize that this may be 
because new TB cases in areas of high TB incidence are overwhelming attributed to 
ongoing community transmission, where the general population is at such high risk for TB 
regardless of their HIV status, thus HIV status as well as other clinical factors are less likely 
to be observed to be associated with clustering.  
 The reasons why this association is inconsistent among studies are not entirely 
clear. While HIV seropositivity does not necessarily increase the infectiousness of TB 
cases, it does substantially increase the risk of progression from infection to disease and 
this progression will happen much quicker than in immunocompetent persons. 
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Immunocompetent individuals infected with M. tuberculosis have approximately a 10% 
lifetime risk of developing TB (Hopewell, 2000) with half of the risk occurring in the 
first 1-2 years after infection. However, HIV-infected individuals with latent TB are 
about 20-30 times more likely to develop TB disease than those without HIV, or at a 
rate of 8-10% per year (Daley, 1992). It has also been observed that in some outbreak 
settings, 35-40% of HIV-infected patients exposed to TB in health care or residential 
settings developed active TB disease within 60-100 days of exposure (DiPerri, 1989; 
Daley, 1992). The speed and efficiency by which HIV infected persons develop active 
disease may be the primary reason why they have been observed to be at higher risk for 
clustering in some studies. Although why this positive association has been observed in 
some U.S. studies (Ellis, 1994; Talarico, 2011; Moonan, 2012) and not others (Kempf, 
2005; Rodwell, 2012) is unclear, but it may be related to the heterogeneity of the HIV 
infected population under study. For instance, those immunocompetent HIV infected 
persons (i.e. those people being effectively treated for their HIV and/or in early HIV 
infection with high CD4 counts) probably do not experience quicker progression from 
TB infection to disease while those who are immunocompromised do experience 
quicker progression to TB disease. 
 Previous TB Diagnosis (yes). Very few studies on risk of TB clustering have 
examined previous TB diagnosis as a risk factor. Most investigators choose to examine 
previous TB treatment instead because previous TB treatment is associated with both 
clustering and MDR-TB. Unfortunately, in my dataset I did not have complete and 
verifiable information on previous TB treatment for many of my cases. Thus, this 
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investigation examined previous TB diagnosis as a risk factor because it had the least 
missing data. Previous TB diagnosis may be interpreted a few different ways. It could 
mean (1) previously diagnosed untreated TB, (2) previously diagnosed treated TB, (3) 
previously diagnosed TB occurring long enough in the past to be considered a separate 
incidence or activation, and (4) or recent TB diagnosis outside the area of the current 
public health system. However, according to the RVCT training manual a previous TB 
diagnosis has a very specific case definition. A patient is considered to have had a 
previous diagnosis of TB disease if TB disease was verified in the past or the patient 
completed therapy for TB disease (even if the case-to-case interval is within 12 
months); or the patient with TB disease was lost to supervision for more than 12 months 
and now has verified TB disease again. The RVCT also notes that recurrent cases 
within 12 months of completion of therapy should be considered previous diagnoses 
regardless of whether the initial and the subsequent genotypes are the same or are 
different (CDC, June 2009). The RVCT further emphasizes that written documentation 
of the previous episode of TB disease is ideal. Nevertheless, states that if the TB disease 
episode occurred years ago or in another location (e.g., other country); oral report of a 
previous episode of TB disease is acceptable only when written documentation is not 
available. Due to the strictness of the previous TB diagnosis case definition and 
verification, I suspect this covariate to be of high validity in my sample. 
 In one recent study that examined previous TB, diagnosis the population was 
Londoners. Hamblion and co-authors found previous TB diagnosis to be significantly 
associated with clustering with an aOR of 2.1 (95% C. I. 1.5–3.0) (Hamblion, 2016). It 
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is also worthwhile to discuss studies that have examined prior TB treatment as a risk 
factor because prior TB treatment is also used to define prior TB diagnosis (on the 
RVCT). A few studies have observed that having received previous TB treatment is a 
risk factor for clustering. A South African study compared cases that were retreated for 
TB after non-compliance from previous treatment compared to the reference group of a 
newly treated cases and found an aOR of 2.36 (95% C.I. 1.08-5.13) for clustering 
(Verver, 2004). In England, Love and co-authors observed an aOR of 3.7 (95% C.I. 2.2-
6.5) for risk of clustering when comparing retreated cases versus new cases. Likewise, 
Chan-Yeung and colleagues found an aOR 6.12 (95% C.I. 1.82-20.5) for clustering 
when comparing retreated cases to new cases (Chan-Yeung, 2006). It is not entirely 
clear why this may be occurring. Most U.S. studies have either not examined this 
relationship or have not found an association. However, some studies have examined 
previous TB diagnosis and found this to be a risk factor for clustering. Previous 
treatment for TB may be an indicator of patient non-compliance for current treatment as 
persons that have relapsing TB are likely to have this due to treatment failure or non-
compliance. Treatment non-compliance and relapsing TB facilitate the spread even 
among communities with comprehensive TB control programs. 
Rates of Clustering and Recent Transmission 
 Because the literature suggests that in population-based studies TB isolates 
sharing identical genotype profiles (also known as clustered isolates) are likely a result of 
recently acquired infection (Driver, 2006; Ellis, 2002) many of these studies approximate 
what proportion of TB in their population may be due to recent transmission from their 
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cluster analysis. Because the proportion of recent TB transmission is a reflection of the 
success of control measures, correctly accessing this is of public health importance. 
Research Question 1(b) approximated recent transmission for my study population. 
Studies have found varying rates of TB clustering and recent transmission among 
different populations. Some clustering studies do not estimate the rate of recent 
transmission from their clustering rates due to limitations of their study design. Table 1 
summarizes these rates. 
Table 1 
 
Rates of Tuberculosis Clustering and Recent Transmission Observed in Previous Population-
Based Studies 
 
Study (First Author, Publication Year, 
Location) 
Time 
Frame 
Cases 
(N) 
Clustering 
(%) 
Recent 
Transmission 
(%) 
Small (1994), San Francisco 
1991-
92 473 40.0 not estimated 
Samper (1997), Zaragoza (Spain) 1993 226 39.0 not estimated 
Barnes (1997), Central Los Angeles 
1994-
96 162 59.0 not estimated 
van Soolingen (1999), The Netherlands 
1993-
97 4,266 46.2 not estimated 
Verver (2001), South Africa                      
1993-
98 797 72.0 not estimated 
Moro (2002), Milan (Italy) 
1995-
97 581 41.1 28.1 
Kulaga (2002), Montreal 
1997-
98 243 7.0 4.0 
Diel (2002), Hamburg (Germany) 
1997-
99  423 33.9 20.6 
Ellis (2002), U.S. 7 Sentinel States 
1996-
00 10,752 48.0 not estimated 
Hernandez-Garduno (2002), 
Vancouver 
1996-
00 793 17.3 not estimated 
Weis (2002), Tarrant County (Texas) 
1995-
96 159 48.0 36.0 
Maguire (2003), London 
1995-
97 2,042  22.7 14.4 
Pena (2003), Gran Canaria (Spain) 1993- 145 72.3 58.5 
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96  
Zolnir-Dovc (2003), Slovenia   2001 301 37.9 25.0 
Cattamanchi (2005), San Francisco 
1991-
03 2,094 18.9 not estimated 
Cacho-Calvo (2005), Madrid (Spain) 
1992-
98 448 50.7 not estimated 
Kempf (2005), Alabama 
1994-
00 1,834 41.0 35.0 
Chan-Yeung (2006), Hong Kong 
1999-
00 702 24.5 15.3 
Driver (2006), New York City 
2001-
03 2,408 36.2 27.4 
Fok (2007), 17 countries-Meta 
Analysis 
1988-
02 
88-
10,752 7.0-72.3 not estimated 
Durmaz (2007), Malatya (Turkey) 
2001-
04 306 22.0 13.1 
Love (2008), England 1998 2,265 16.4 12.2 
Franzetti (2010), Italy 
1993-
00 1,999 46.0 not estimated 
Talarico (2011), Arkansas 
1996-
03 993 39.5 not estimated 
Kamper-Jorgensen (2012), Denmark 
1990-
05 4,601 56.0 not estimated 
Rodwell (2012), Southern California 
2005-
08 832 58.0 45.0 
Moonan (2012), United States 
2005-
09 36,860 23.1 23.1 
 
Genotyping and Multidrug Resistant TB 
 One of the important uses of TB genotyping globally is to examine the strains 
that are most frequently observed as multidrug resistant. The U.S. population has not 
had extensive spread of multidrug resistant TB thus far. Most cases of MDR-TB in the 
U.S. have been imported from countries where it is an increasing public health problem. 
However, when isolated cases are detected in the U.S. it is important to determine the 
source and the genotype of each case quickly so that local transmission can be ruled out. 
This section of my literature review will discuss the importance of TB genotyping as a 
tool to describe and combat MDR-TB. 
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 The European Concerted Action on New Generation Genetic Markers and 
Techniques for the Epidemiology and Control of Tuberculosis conducted a meta-
analysis to determine how widespread the Beijing/W genotype of M. tuberculosis was, 
whether it was on the increase, and whether it had a tendency for drug resistance 
(2006). Individual-level data on >29,000 patients from 49 studies in 35 countries were 
combined to assess the Beijing genotype's prevalence worldwide and drug resistance. 
The authors found four patterns for Beijing/W genotype TB, which they described as 
follows:  
1. endemic, not associated with drug resistance at high levels in most of East Asia, 
lower levels in parts of the US; 
2. epidemic, associated with drug resistance at a high levels in Cuba, the former 
Soviet Union, Vietnam, and South Africa, lower levels in parts of Western 
Europe;  
3. epidemic but drug sensitive in Malawi and Argentina; and  
4. very low levels or absent in parts of Europe and Africa.  
This essential study established that Beijing/W genotype TB was an emerging in several 
regions and a predominant endemic strain in others. It was also frequently associated 
with drug resistance. 
 A study by Shubladze and colleagues from Georgia (in the former Soviet Union) 
was conducted on 634 MDR-TB strains were examined for which an MDR phenotype 
had been previously determined by the proportions method (2013). This study 
investigated the frequency of major drug resistance mutations across rpoB, katG and 
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inhA loci of Georgian MDR-TB strains and explored differences between new and 
previously treated patients. Rifampin resistance was seen in 92.9% of patients and INH 
resistance was seen in 92.1% of patients; 67.2% and 84.3% of MDR strains harbored 
respectively rpoB S531L and katG S315T mutations. The inhA C15T mutation was 
detected in 22.6% of the strains, whereas rpoB H526D, rpoB H526Y, rpoB D516V and 
inhA T8C were revealed at a markedly lower frequency (≤ 5.2%). The specific 
mutations responsible for the rifampin resistance of 110 isolates (17.4%) could not be 
detected as no corresponding mutant probe was indicated in the assay. All types of 
predominant mutations were observed at higher levels in new cases. Authors concluded 
that a large portion of Georgian MDR-TB strains have a strong preference for the drug 
resistance mutations. Further, investigators surmised that MDR TB strains with these 
mutations might continue to occur in Georgia even in the absence of antibiotic pressure. 
 A Mexican study by Macías and co-investigators whose goal was to determine 
the frequency of drug resistance and the clonality of genotype patterns in M. 
tuberculosis clinical isolates from pediatric patients (2011). Resistance to any anti-TB 
drug was detected in 26.7% of the isolates; 23.3% and 11.1% were resistant to Isoniazid 
and Rifampicin, respectively, and 11.1% strains were MDR-TB. Spoligotyping 
produced 55 different patterns; 12/55 corresponded to clustered isolates (n = 47, 
clustering rate of 52.2%), and 43/55 to unclustered isolates (19 patterns were designated 
as orphan by the SITVIT2 database). Database comparison led to labeling of 36 shared 
types (SITs); 32 SITs (n = 65 isolates) matched a previous shared type in SITVIT2, 
whereas four SITs (n = six isolates) were newly created. Lineage classification based on 
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principal genetic groups (PGG) showed that 10% of the strains belonged to Bovis and 
Manu lineages. Among the Bovis and Manu group, the most predominant clade was the 
Latin-American and Mediterranean (LAM) in 27.8% of isolates, followed by Haarlem 
and T lineages. The number of single drug-resistant (DR) and MDR-TB isolates in this 
study was consistent with prior studies in adult populations with risk factors.  
 Dhatwalia and colleagues conducted a study to determine the prevalence of 
different genotypes and examine their association with drug resistance among clinical 
isolates of M. tuberculosis from the northern region of India. Investigators analyzed 100 
clinical isolates of M. tuberculosis using MIRU genotyping and TbD1 analysis. The 
analysis showed that 34% of strains belonged to the Delhi/CAS lineage, 32% had 
unknown patterns (27 TbD1-, 5 TbD1+), 18% were of Beijing genotype and 11% were 
of EAI lineages. Twenty-one strains were MDR-TB, nine of which belonged to the 
Delhi/CAS lineage, four were of Beijing lineage, six were of unknown pattern and one 
was of EAI lineage. Their analysis showed the overall proportion of CAS lineage to be 
42.96% (95%CI 33-52); the CAS lineage had no association with MDR-TB (OR 0.89, 
95%CI 0.66-1.20). This study indicated that the distribution and identification of 
different genotypes of M. tuberculosis could facilitate better understanding of the 
dynamics that influence disease transmission and drug resistance.  
 In summary, TB genotyping has been used to successfully describe geographic 
areas of high TB drug resistance and, in some cases predict continued spread of drug-
resistance. These studies underscore the need to continue to develop and expand 
genotyping capabilities globally as MDR-TB and XDR-TB continue to emerge. 
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Summary and Conclusions 
 This literature review provided background and evidence for my conceptual 
framework, explained the rationale for my choice of statistical analysis, summarized 
research on the risk factors for clustering, and reviewed clustering and recent 
transmission rates observed in previous studies. Several population-based molecular 
epidemiology studies have been conducted to estimate the extent of ongoing TB 
transmission and to characterize recent transmission dynamics in different geographic 
regions. Additionally, many of these studies have investigated risk factors for clustering by 
comparing the characteristics of clustered and nonclustered cases. Some characteristics that 
studies have consistently found to be associated with being part of a TB genotype cluster 
were being native-born, being male, younger age, history of alcohol abuse, black race, and 
history of homelessness. Some characteristics that studies have inconsistently found to be 
associated with being part of a TB genotype cluster were being HIV positive, having 
pulmonary disease, and illicit drug use. Better knowledge of transmission risk factors may 
help to develop more effective prevention strategies to target high-risk populations. The bulk 
of TB cases in developed countries with comparatively low TB incidence were once thought 
to be due to the reactivation of infection acquired in the past. Since the advent of molecular 
epidemiology, TB genotyping studies have strongly suggested that there is greater ongoing 
transmission and development of active disease than previously appreciated. A better 
understanding of the factors that influence TB transmission is therefore vital in the global 
effort to control TB. The purpose of this research was to estimate the proportion of TB in 
South Carolina that may be due to recent transmission, and determine the risk factors 
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associated with the genotype clustering of identical M. tuberculosis isolates from TB 
patients in South Carolina from 2005-2011. The social change implication of this study 
was to further TB elimination by elucidating risk factors for ongoing transmission in 
South Carolina, thereby informing the South Carolina TB Control Program and other 
states’ control efforts. Chapter 3 will discuss the methodology of the study including the 
population, sample size, data collection techniques, and data analysis procedures.  
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Chapter 3: Methodology 
 In this chapter, I describe the research methodology used in this study, including 
the rationale for the study design, the setting of the study, the study participants, the 
instrumentation, the data collection, and the data analysis plan. I also discuss the 
relevant ethical considerations. The goal of the study was to determine the risk factors 
associated with genotype clustering of identical M. tuberculosis isolates, and to estimate 
the proportion of South Carolina TB that could be due to recently acquired infection. 
Study Design and Rationale 
 I used a cross-sectional approach to determine what risk factors among incident 
cases of TB from 2005 to 2011 in South Carolina were significantly associated with 
being a part of an identical TB genotype cluster of two or more cases. The risk factor 
assessment for all confirmed cases of TB in South Carolina occurred at the time of TB 
diagnosis (usually a few weeks prior to the determination of the case’s genotype). 
Because risk factors were queried after TB disease had manifest, the RVCT assessment 
was considered cross-sectional in nature. However, for the purposes of this study, as has 
been the case in most studies of this kind, many of the risk factors I examined could be 
assumed to have preceded TB diagnosis and in some circumstances, TB infection. The 
risk factors analyzed as covariates were as follows: being U.S. born, being male, being 
younger, being Black, being Hispanic, history of homelessness, history of incarceration, 
history of alcohol abuse, history of illicit drug abuse, being HIV positive, and previous 
TB treatment. Those risk factors for which it cannot be determined whether they 
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preceded diagnosis are noted (as cross-sectional in nature) and interpreted accordingly in 
Chapter 5.  
 Cross-sectional study designs have been used frequently to study risk factors for 
TB genotype clustering (Oeltmann, 2008; Ricks, 2011; Moonan, 2012). A cross-sectional 
study design has some advantages, for example, it is a low-cost design and the resulting 
odds ratios are simple to calculate and easy to interpret (Creswell, 2009). However, cross-
sectional designs have limitations. The most important limitation is that they are unable 
to determine whether the risk factor precedes the outcome of interest. This means that a 
statistically significant association maybe illuminated between two factors but the 
temporality of an exposure and outcome cannot be established in a cross-sectional study, 
and thus causality cannot be established. However, in addition to the low cost and ease of 
working with the resulting odds ratios, there are two other important points in defense of 
the cross-sectional design. First, a general point: Even when temporality may be 
established, such as with the longitudinal cohort design (for instance, one that results in a 
strongly associated exposure and outcome); this, in and of itself, does not necessarily 
establish causality. Temporality is but one of several criteria for causality. Bradford Hill’s 
original nine criteria for causality are: (1) strength of association (2) temporality (3) 
consistency (4) biological plausibility (5) coherence (6) specificity in the causes (7) dose 
response relationship (8) experimental evidence and (9) analogy. All of these criteria are 
rarely applied in modern epidemiology, and Rothman and Greenland have been critics of 
them for reasons they explain in “Causation and Causal Inference in Epidemiology” 
(Rothman & Greenland, 2005), most schools of Public Health still teach at least five of 
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them. Those are (1) strength of association (2) temporality (3) consistency (4) biological 
plausibility and (7) dose response relationship. Thus, even though a longitudinal design is 
advantageous over a cross-sectional design in that temporality may be established, it may 
not necessarily establish causality any more than a cross-sectional study. The second 
point is that many of the risk factors examined in this study may be assumed to have 
preceded TB diagnosis/disease. Thus, temporality was established due to the nature of the 
risk factor. Table two lists each covariate examined, whether it could or could not 
reasonably be assumed to have preceded TB diagnosis, and whether it could or could not 
reasonably be assumed to have preceded TB disease/infection.  
Table 2 
 
Chronology of Potential Risk Factors for Tuberculosis Genotype Clustering 
 
Risk factor 
Did this 
proceed TB 
diagnosis? 
Did this 
proceed TB 
disease/ 
infection? 
Age Yes Yes 
Sex at Birth Yes Yes 
Race Yes Yes 
Ethnicity Yes Yes 
Being U.S. Born                            Yes Yes 
HIV Status Unknown Unknown 
Homeless within the Past Year Unknown Unknown 
Resident in a Correctional Facility 
at the Time of Diagnosis Yes Unknown 
Alcohol Abuse  Yes Unknown 
Drug Abuse Yes Unknown 
Injection Drug Use Yes Unknown 
Previous TB Diagnosis Yes Yes 
 
69 
 
 
Setting of the Study and Population 
 The setting of this study was the state of South Carolina from 2005 to 2011. The 
population of South Carolina ranged from 4,012,012 in 2005 to 4,625,401 in 2010. The 
incidence of TB in South Carolina ranged from 6.1 in 2005 to 3.0 per 100,000 population 
in 2011 (1,346 TB confirmed cases in those 6 years. All South Carolina residents were 
considered at risk for TB in the years preceding, during, and after this study. The 
sampling frame for this study was confirmed cases of TB disease (n = 1,346) excluding 
all exclusively extrapulmonary TB (n = 266) in South Carolina from 2005 to 2011, for a 
total sampling frame of 1,080 pulmonary (including pleural) or both pulmonary 
(including pleural) and extrapulmonary TB disease. This study did not use any sampling 
procedures and all TB cases for which my dataset contained a valid genotype were 
considered in the study analysis. The analysis dataset contained a valid genotype for 63% 
of eligible cases in the sampling frame (n = 685) (see Table 3). This study did not use any 
sampling procedures for two reasons. First, I wanted to use all genotype data available to 
maximize statistical power. Second, as mentioned in Chapter 2 Limitations, I did not 
have complete demographic, clinical, or social information on TB cases for which I did 
not have a valid genotype. Thus, I did not have an entirely accurate way to verify the 
randomness or accuracy of my sampling methodology. Table 3 displays South Carolina 
TB statistics for 2005 through 2011, the associated sampling frame, and sample size per 
year. 
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Table 3 
 
The Percentage of Confirmed Tuberculosis Cases in South Carolina with a Genotype 
Determined, 2005-2011 
 
Year 
Confirmed 
Cases 
Case 
Ratea 
Eligible 
for 
Genotypeb 
Successfully 
Genotyped 
Genotyping 
Ratec 
2005 261 6.1 214 126 59% 
2006 222 5.1 178 105 59% 
2007 218 4.9 175 116 66% 
2008 188 4.2 146 95 65% 
2009 164 3.6 138 85 62% 
2010 153 3.3 121 84 69% 
2011 140 3.0 108 74 69% 
Total 1,346 3.0-6.1 1,080 685 63% 
a Rate per 100,000 population.  
b Cases with pulmonary (including pleural) TB (may have both pulmonary and 
extrapulmonary). 
c Rate calculated as cases genotyped per year/eligible for genotype. 
Instrumentation 
 All information on covariates of interest for this study was obtained from the 
RVCT. There is a copy of the RVCT displayed in Appendix A. The Centers for Disease 
Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB 
prevention developed and owns all versions of this form. This form is provided to all 
states for the purposes of collecting and reporting information to the CDC TB division on 
all suspect and confirmed TB cases identified in the states. A training manual is provided 
to state and local health departments on how to complete this form. All South Carolina 
health department TB nurses are required to attend an in-person training on completing 
this form. The CDC website states that the form may be used for relevant research 
purposes, but should be properly bibliographed.  
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Below, the specific questions on this form that were used for this study are listed 
in the order in which they appear on the form.  
1. Date of Birth (MM/DD/YYYY),  
2. Sex at Birth (Male, Female),  
3. Race (American Indian or Alaskan Native, Asian: Specify, Black or African 
American, Native Hawaiian or Other Pacific Islander: Specify, White),  
4. Ethnicity (Hispanic or Latino, Not Hispanic or Latino),  
5. Country of Birth (U.S. born or born to a parent who is a U.S. citizen, Country of 
Birth: Specify),  
6. Month-Year arrived in the U.S. (MM/YYYY),  
7. Site of TB Disease (Pulmonary, Pleural, Lymphatic: Cervical, Lymphatic: 
Intrathoracic, Lymphatic: Axillary, Lymphatic: Other, Lymphatic: Unknown, 
Laryngeal, Bone and/or joint, Genitourinary, Meningeal, Peritoneal, Other: Enter 
Anatomic Code, Site not Stated),  
8. HIV Status (Negative, Positive, Indeterminate, Refused, Not offered, Test Done, 
Results unknown, Unknown),  
9. Homeless within the Past Year (No, Yes, Unknown),  
10. Resident in a Correctional Facility at the Time of Diagnosis (No, Yes, Unknown, 
if Yes select one: Federal Prison, State Prison, Local Jail, Juvenile Correction 
Facility, Other Correctional Facility, Unknown),  
11. Alcohol abuse use in the Past Year (No, Yes, Unknown), 
12. Injection Drug use in the Past Year (No, Yes, Unknown),  
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13. Non-injection Drug use in the Past Year (No, Yes, Unknown), and 
14. Prior TB disease diagnosis (No, Yes, Unknown). 
 The literature review found no reliability or validation studies for the RVCT 
instrument used as part of the original data collection. However, in Table 4, I have listed 
all the studies on risk factors of TB genotype clustering that have used all or part of the 
RVCT as their primary data collection/abstraction source. All of these studies were 
published in reputable peer-reviewed journals. The limitations of the RVCT form were 
described Chapter 1: Introduction of Study—Limitations and are described further in 
Chapter 5: Conclusions and Recommendations. 
 
Table 4 
 
Peer-Reviewed Studies Utilizing the Report of a Verified Case of Tuberculosis (RVCT) 
 
First Author 
(Publication Year) Study Title Publication 
Driver (2006).  
Molecular epidemiology of tuberculosis 
after declining incidence, New York 
City, 2001-2003.  
Epidemiology & 
Infection 
Driver (2006).  
Which patients’ factors predict the rate 
of growth of Mycobacterium 
tuberculosis cluster in an urban 
community?  American J of Epi 
Kempf (2005).  
Long-term molecular strains in 
Alabama, a state characterized by a 
largely indigenous, low-risk population.   J of Clinical Micro. 
Moonan (2012).  
Using genotyping and geospatial 
scanning to estimate recent 
Mycobacterium tuberculosis 
transmission, United States.  Emer Infectious Dis 
Oeltmann (2009).  
Tuberculosis and substance abuse in the 
United States, persons acquired prior to 
entering the U.S., 2005-2009.  Arch of Internal Med 
(table continues) 
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Ricks (2011).  
Estimating the burden of tuberculosis 
among foreign-born persons acquired 
prior to entering the U.S., 2005-2009.  Public Library of Science 
Rodwell (2012).  
Factors associated with genotype 
clustering of Mycobacterium 
tuberculosis isolates in an ethnically 
diverse region of southern California, 
United States.  Infect. Genetic Evol 
Talarico (2011).      
Identification of factors for tuberculosis 
transmission via an integrated 
multidisciplinary approach Tuberculosis 
 
Data Collection 
There were no recruitment procedures used in this study because the study is 
based entirely on secondary data collected through normal TB case investigation and 
confirmation procedures. The original data was collected as part of a South Carolina TB 
case investigation. These investigations occurred for all suspected and confirmed cases of 
TB in South Carolina, which is a requirement of all states receiving federal TB control 
and prevention funding.  
Data Analysis Plan 
 I constructed the methodology of my study to answer the following research 
questions. 
Research Question 1:  
a) Using the mycobacterial interspersed repetitive unit (MIRU) genotyping 
method, and spoligotyping, for cluster classification of tuberculosis cases in 
South Carolina, I estimated the proportion of TB cases that were genotyped 
clustered versus singleton?  
b) Estimated the proportion of South Carolina TB cases that may be due to 
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recently acquired infection the following logic was applied: 
I. For genotype clusters of only 2 cases: One case of the cluster was 
assumed to be a souce case. One case of the cluster was assumed to be 
the recently infected case.  
II. For genotype clusters of 2 or more cases: One case of the cluster was 
assumed to be the source case. All other matches in the cluster were 
assumed to be due to recent transmission.  
Thus, C - 1, were counted as recently transmitted cases, where C was the 
number of identical isolates in the cluster (based on the “n - 1 method” index 
described previously). 
Research Question 2: Determined the risk factors of genotype clustering among 
incident South Carolina TB cases from 2005 to 2011 considering the following 
hypotheses: 
H0  There is no relationship between being foreign-born and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being foreign-born and being part 
of a TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between being foreign-born and being part 
of a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between age and being part of a TB genotype 
cluster when controlling for other significant covariates. 
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Ha1  There is a positive relationship between age and being part of a TB 
genotype cluster when controlling for other significant covariates.  
Ha2  There is a negative relationship between age and being part of a TB 
genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between being male and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being male and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between being male and being part of a 
TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between black race and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between black race and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between black race and being part of a TB 
genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between hispanic ethnicity and being part of a TB 
genotype cluster when controlling for other significant covariates. 
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Ha1  There is a positive relationship between hispanic ethnicity and being part 
of a TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between hispanic ethnicity and being part 
of a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between residence in a correctional facility at the 
time of diagnosis and being part of a TB genotype cluster when 
controlling for other significant covariates. 
Ha1  There is a positive relationship between residence in a correctional facility 
at the time of diagnosis and being part of a TB genotype cluster when 
controlling for other significant covariates. 
Ha2  There is a negative relationship between residence in a correctional facility 
at the time of diagnosis and being part of a TB genotype cluster when 
controlling for other significant covariates. 
 
H0  There is no relationship between homelessness within the past year and 
being part of a TB genotype cluster when controlling for other significant 
covariates. 
Ha1  There is a positive relationship between homelessness within the past year 
and being part of a TB genotype cluster when controlling for other 
significant covariates. 
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Ha2  There is a negative relationship between homelessness within the past year 
and being part of a TB genotype cluster when controlling for other 
significant covariates. 
 
H0  There is no relationship between being HIV positive and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between being HIV positive and being part 
of a TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between being HIV positive and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
 
H0  There is no relationship between alcohol abuse and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between alcohol abuse and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between alcohol abuse and being part of a 
TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between illicit drug use and being part of a TB 
genotype cluster when controlling for other significant covariates. 
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Ha1  There is a positive relationship between illicit drug use and being part of a 
TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between illicit drug use and being part of a 
TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between injection drug use and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between injection drug use and being part 
of a TB genotype cluster when controlling for other significant covariates. 
Ha2  There is a negative relationship between injection drug use and being part 
of a TB genotype cluster when controlling for other significant covariates. 
 
H0  There is no relationship between substance abuse and being part of a TB 
genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between substance abuse and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between substance abuse and being part 
of a TB genotype cluster when controlling for other significant 
covariates. 
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H0  There is no relationship between having prior TB disease and being part of 
a TB genotype cluster when controlling for other significant covariates. 
Ha1  There is a positive relationship between having prior TB disease and being 
part of a TB genotype cluster when controlling for other significant 
covariates. 
Ha2  There is a negative relationship between having prior TB disease and 
being part of a TB genotype cluster when controlling for other significant 
covariates. 
 My secondary dataset was provided in a Microsoft excel passphrase-encrypted 
spreadsheet. For security reasons, the passphrase was provided verbally and was not 
transcribed. For the analysis phase of this study, I imported the excel data into SAS 9.3. 
SAS 9.3 was used to conduct all analysis. I cleaned the data as necessary by labeling, 
formatting, and making sure all values were reasonable and valid. As mentioned in 
Chapter 2, logistic regression is commonly used in cross-sectional studies to model the 
relationship between a binary dependent variable and one or more explanatory or 
independent variables (Hosmer & Lemeshow, 2000) and I used it to model my data. I 
used SAS code to format the genotype variable, which was my dependent variable. I 
examined how many different clusters were present in the data, the range of cluster size, 
and what proportion of cases were clustered (had one or more matches) versus 
singleton. I coded the dependent variable of interest called “clustered status” as a 
character variable of “0” for singleton cases and “1”for clustered cases. The 
independent variables were obtained from the questions on the RVCT.  
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 Independent variables. The rationale for inclusion of the covariates chosen was 
that these factors have been found to be statistically significant risk factors of TB 
genotype clustering in multiple previous studies (Love, 2009; Barnes, 1997; Cacho-
Calvo, 2005; Cattamanche, 2006; Fok, 2008; Kempf, 2005; Chan-Yeung, 2006; Driver, 
2006, Ellis, 2002). Categorical variables with two levels are coded as “1” for the level 
that has been observed in the literature to be positively associated with being part of a 
TB genotype cluster, and “0” for the other level. Country of birth was coded with “0” 
assigned to foreign-born and “1” assigned to U.S. born. Date of birth was not provided 
in the dataset, only age categories (so age was modeled as categorical variable rotating 
both younger and older age groups as the risk factor see Chapter 5 Results for more 
information). Sex was coded with “0” assigned to females and “1” assigned to males. 
Race was a categorical variable divided as (1) White (2) Black (3) Hispanic, (4) Asian, 
and (5) Other (the “Other” category was the collapsed category of American Indian or 
Alaskan Native and Native Hawaiian or Other Pacific Islander). Homeless within the 
past year was “0” as no and “1” as yes. Resident in a correctional facility at the time of 
diagnosis was “0” for no and “1” for yes. HIV status was “0” for negative and “1” for 
positive. Prior or current alcohol abuse was “0” for no and “1” for yes. Prior or current 
drug abuse was “0” for no and “1” for yes. Prior TB diagnosis was coded as “0” for no 
and “1” for yes. 
 By definition, confirmed TB cases that are HIV positive have AIDS because TB 
is one of several conditions that coupled with HIV infection is an AIDS-defining 
condition. Thus, TB cases may or may not be aware of their HIV infection before their 
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TB diagnosis. However, once a patient tests positive for HIV concurrently with their TB 
diagnosis they actually have three new diagnoses: HIV infection, ‘full-blown’ AIDS, 
and TB disease. For this reason, all HIV positive people in my study population were 
considered AIDS patients and analyzed as part of an HIV seropositivity, inclusive of all 
HIV and AIDS cases, covariate analysis. This analysis did not attempt to distinguish 
those HIV positive persons that may or may not have been diagnosed with AIDS prior 
to their TB diagnosis. Most other studies also assess HIV seropositivity in this way and 
do not perform a subset analysis of AIDS cases alone or any analysis by immune-
competence among HIV infected persons.  
 This study used a bivariate and multiple regression statistical analysis. This 
approach made it possible both clarification of bivariate relationships, as well as a 
determination of the degree of relationship between and among variables (Kleinbuam, 
1988). A multiple logistic regression approach was appropriate for this study because it 
allowed simultaneous consideration of multiple predictor variables for a binary outcome 
variable, and subsequent stepwise model building (Hosmer, 1989). First, the bivariate 
results of all risk factors were examined. Then multiple logistic regression analysis and 
a stepwise modeling building process included variables with an alpha level of 0.10. For 
a covariate to be included in the final model, it was statistically significant with a p-
value < 0.05. The odds ratio results from this analysis were examined and interpreted in 
the context of the bivariate and multivariable analysis. Model fit statistics were 
examined and interpreted. As is customary, odds ratios >1.0 with an associated p-value 
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< 0.05 were interpreted as a risk factor for clustering. Likewise, odds ratios < 1.0 with 
an associated p-value < 0.05 were interpreted as protective for clustering. 
Ethical Considerations 
 For this study, I obtained Institutional Review Board (IRB) approval through 
Walden University on March 17, 2017 (3-17-17-0080120). As a full-time employee of 
the South Carolina DHEC Division of Infectious Disease Control, they provided me 
patient-level identifiable data in the summer of 2012 by South Carolina DHEC. This data 
was not available to the public. I was allowed to view this data as part of my job and it 
was covered under the confidentiality agreement I had to sign and adhere to as an 
employee. Since my departure from South Carolina DHEC, I have been covered under 
the volunteer use agreement as a non-employee.  
 At the time of my employment, one identifiable passphrase-encrypted dataset was 
kept on the South Carolina DHEC desktop computer for which I alone had passphrase-
protected access. During the time of my employment, South Carolina DHEC procedures 
for patient data protection were strictly followed including that identifiable data could 
never be emailed, and it could only be shared with disease investigation staff who had 
appropriate access rights. At the time just prior to my separation from South Carolina 
DHEC, I de-identified all data that was to be used in this study. I de-identified the data 
using the following procedures: 
1. I created a randomly generated unique identifier for all subjects.  
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2. I deleted all personal identifiable variables for each subject including first name, 
last name, South Carolina TB case number, CDC TB case number, and patient 
address including city, street, and zip.  
3. I created an alias variable for HIV status. The term “HIV” or “AIDS” was not 
included in any of the data I am using. 
4. I deleted all variables except those pertinent to my analysis including any 
variables or opened-ended comments that included the names of HIV related 
medications. 
 The one original copy of the data I was provided was completely deleted and I 
have had no access to identifiable data since my departure from South Carolina DHEC 
in October of 2012. Per my volunteer data-use agreement (DUA) with South Carolina 
DHEC, a copy of the de-identified data (described above) was placed on an encrypted-
password-protected jump drive. That data was then placed on my personal laptop in an 
encrypted password protected file and the jump drive file was deleted. Entry to my 
personal laptop was password protected and I was the only person that had access to 
this data. 
 Informed consent was not obtained from any individual for this study for the 
following reasons. (1) Inclusion of a subjects de-identified data did not pose any physical 
or mental risk to the subjects. Any risks associated with primary data collection (such as 
obtaining a TB specimen for diagnosis and genotyping, or TB treatment) would have 
occurred as a part of the normal TB diagnosis and treatment procedures. The low to 
moderate risks associated with TB diagnosis and treatment far outweigh the risks of 
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having untreated and undiagnosed TB disease for the individual. Further, TB 
investigation, diagnosis, treatment, and containment are required by South Carolina State 
Law Title 44 – Health, Chapter 31 Tuberculosis, and Article 1. Any use of a patient’s 
secondary data in no way contributed to those risks. (2) Data was provided to only myself 
for the purposes of this study 2 to 8 years after it was originally collected, and all 
identifiers were dropped from the data, thus subjects were not identifiable for which to 
obtain informed consent. All descriptive data and results are displayed at an aggregate 
summary level in this report and there was no risk of individual identification. 
Summary 
 In this chapter, I discussed the rational for the study design, setting of the study, 
study participants, instrumentation, data collection, data analysis plan, and any ethical 
considerations. Cross-sectional study designs have been used in previous retrospective 
population-based TB genotyping studies, and this was a reasonable and appropriate 
approach for my study. Each research question was described. Bivariate and multiple 
logistic regression analysis were used to calculate odds ratios for each covariate 
examined in this study.  
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Chapter 4: Data Analysis 
The purpose of this research was to estimate the proportion of South Carolina 
TB that may be due to recently acquired infection, and determine the risk factors 
associated with the genetic clustering of identical M. tuberculosis isolates from TB 
patients in South Carolina from 2005-2011 by using a multivariable logistic regression 
technique to model risk factors for the binary outcome of being part of a TB genotype 
cluster, yes or no. In this study, two research questions were tested by using appropriate 
statistical methods. This chapter presents an overview of the results and findings of 
these analyses. 
Data Collection and Study Participants 
 I used a cross-sectional approach to determine the risk factors among incident 
cases of TB from 2005 to 2011 in South Carolina that were significantly associated with 
being a part of an identical TB genotype cluster of two or more cases. This study was 
based entirely on secondary data collected through normal TB case investigation and 
confirmation procedures. The incidence of TB in South Carolina ranged from 6.1 per 
100,000 population in 2005 to 3.0 per 100,000 population in 2011, or 1,346 confirmed 
TB cases over those 6 years. The sampling frame for this study was confirmed cases of 
TB disease (n = 1,346), excluding all exclusively extrapulmonary TB (n = 266) in South 
Carolina from 2005 to 2011, for a total sampling frame of 1,080 pulmonary (including 
pleural) or both pulmonary (including pleural) and extrapulmonary TB disease. The 
analysis dataset contained a valid genotype for 63% (685/1,080) of cases in the sampling 
frame (see Table 3), or 50.9% (685/1,346) of all confirmed South Carolina TB cases from 
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2005 to 2011. The study population was 685 confirmed cases of TB for which a valid 
genotype was available. Table 5 displays South Carolina TB statistics from 2005 through 
2011, including the associated sampling frame and sample size per year.1). 
Table 5 
 
The Percentage of Confirmed Tuberculosis Cases in South Carolina with a Genotype Determined, 2005-
2011 
 
Year 
Confirmed 
Cases Case Ratea 
Eligible for 
Genotypeb 
Successfully 
Genotyped 
Genotyping 
Ratec 
2005 261 6.1 214 126 59% 
2006 222 5.1 178 105 59% 
2007 218 4.9 175 116 66% 
2008 188 4.2 146 95 65% 
2009 164 3.6 138 85 62% 
2010 153 3.3 121 84 69% 
2011 140 3.0 108 74 69% 
Total 1,346 3.0-6.1 1,080 685 63% 
a Rate per 100,000 population. 
b Cases with pulmonary (including pleural) TB (may have both pulmonary and extrapulmonary). 
c Rate calculated as cases genotyped per year/eligible for genotype. 
 
In order reveal any bias that may have been introduced by not using a sampling 
methodology, I compared the distribution of covariates in the cases that were genotyped 
(the 685 cases of the study population) to all confirmed TB cases in South Carolina (the 
1,346 confirmed TB cases) from 2005-2011. This was done to determine how closely the 
genotyped sample resembled the entire case population. This is discussed in Results, 
under Estimate of Recent Transmission. 
Descriptive Statistics 
 Table 6 below describes the characteristics of the study population. Most cases in 
the study sample were adults with 31% being between 25-44 years, 38% 45-64 years, and 
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20% 65+ years old. Children under 15 years made up less than 1% of the sample. The 
majority of the population was male at 67.6 %. Sixty-three percent of the sample was 
Black, 16% White, 13% Hispanic, and 8% other races. Close to 80% of the cases were 
US-born. Less than 9% were HIV positive. A little under 7% reported having been 
homeless in the last year, and a little over 2% were incarcerated at the time of diagnosis. 
Almost 29% of the study population were heavy drinkers, while over 15% reported illicit 
drug use. Most of the drug users reported non-injection drug use, with only 1.3% 
affirming injection drug use. Eleven percent of the sample were both alcohol and drug 
abusers which is termed “substance abuse” for the purposes of this analysis. Lastly, for 
96% of the study population this represented their first TB diagnosis, while 4% noted a 
previous TB diagnosis. 
Table 6 
 
Summary of Descriptive Statistics for South Carolina Genotyped Tuberculosis Cases, 2005-2011 
 
Genotyped 
Cases 
(N=685) 
Variables N % 
Age (Years) 
00-04 3 0.44 
05-14 1 0.15 
15-24 75 10.95 
25-44 215 31.39 
45-64 259 37.81 
65+ 132 19.27 
Age-Collapsed 
Child (0 - 14 years) 4 0.58 
Adult (15 - 64 years) 549 80.15 
Elderly (65+) 132 19.27 
Sex at Birth 
Male 463 67.59 
Female 222 32.41 
(table continues) 
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Race/Ethnicity 
Black 432 63.07 
Hispanic/Latino 88 12.85 
Asian American 50 7.3 
White 109 15.91 
Other (American Indian, Alaskan Native, 
Native Hawaiian or other Pacific Islander) 6 0.87 
Origin 
US-born 545 79.56 
Foreign-born 140 20.44 
HIV Status 
Negative 571 83.36 
Positive 60 8.76 
Unknown (Refused, Not offered, or 
Missing) 54 7.88 
Homelessness 
Yes 45 6.57 
No 638 93.14 
Unknown 2 0.029 
Correctional Institution 
Yes 15 2.19 
No 670 97.81 
Alcohol 
Yes 195 28.47 
No 485 70.08 
Unknown 5 0.73 
Illicit Drug Use 
Yes 104 15.18 
No 574 83.8 
Unknown 7 1.02 
Non-Injection Drug Use 
Yes 103 15.04 
No 575 83.94 
Unknown 7 1.02 
Injection Drug Use 
Yes 9 1.31 
No 669 97.66 
Unknown 7 1.02 
Substance Abuse 
Yes (yes to alcohol and drugs) 79 11.5 
No (no to either alcohol, drugs, or both) 601 87.7 
Unknown 5 0.73 
Previous TB Diagnosis 
Yes 29 4.23 
No 656 95.8 
 
(table continues) 
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As shown in Table 7, the genotype lineages that occurred in South Carolina TB 
patients between 2005 and 2011 were mostly EuroAmerican and East Asian with a few 
IndoOceanic, East African Indian, Bovis type, and Africanum type. This study revealed a 
modest diversity of circulating genotypes as would be expected in a low incidence region. 
All of the genotypes are fairly common in the US. 
Table 7 
 
Distribution of Genotype Lineages among South Carolina Tuberculosis Cases, 2005-2011 
 
Genotyped Cases 
(N=685) 
Genotype Lineage N % 
Africanum type 2 0.29 
Bovis type 3 0.44 
East African 
Indian 4 0.58 
East Asian 74 10.8 
EuroAmerican 528 77.1 
IndoOceanic 31 4.53 
Unknown 43 6.3 
 
Results 
Estimate of Recent Transmission 
There were 1,346 confirmed cases of TB in South Carolina from 2005 to 2011. Of 
those, a genotype was successfully obtained on 685. For this study, research question 1(a) 
asked what proportion of TB cases in South Carolina are clustered versus singleton? Of 
these 685 cases that were successfully genotyped, 419 were clustered, for a clustering 
rate of 61.2% (419/685). Research question 1(b) asked what proportion of South 
Carolina TB cases might be due to recently acquired infection? There were 76 different 
clusters represented by the 419 clustered cases. Cluster size ranged from two2 to 39 
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cases. As described in Chapter 3 Methodology, for genotype clusters of only two cases, 
one case of the cluster was assumed a source case while one case of the cluster was 
assumed the recently infected case. For genotype clusters of two or more cases, one case 
of the cluster was assumed the source case and all other matches in the cluster were 
assumed to be due to recent transmission. This method is often called the “n – 1 method” 
and has been used in previous research to estimate recent transmission (Reza Allahyar 
Torkaman, 2014; Ricks, 2009). This logic provided the calculation:  
419 (clustered cases) – 76 (source cases) = 343 recently transmitted cases 
This gives a recent transmission estimate of 343/685 or 50.1% for this study population.  
Table 8 below displays the descriptive statistics of all TB cases compared to only 
the genotyped cases. Chi-square analysis was performed to compare all South Carolina 
TB from 2005 to 2011 to those cases that were selectively in 10 characteristics of interest. 
For most characteristics, the genotyped cases were not significantly different from the 
entire South Carolina case population. They were different in three characteristics: age, 
non-injection drug use, and alcohol abuse. Meaning it appears from this analysis that 
middle age and older cases were more likely to be selected for genotyping, abusers of 
non-injections drugs were more likely to be selected for genotyping, and alcoholics were 
more likely to be selected for genotyping. However, other than these three characteristics, 
given that the study population was not randomly sampled (as discussed previously this 
was a convenience sample that included all cases with a genotype for maximum 
statistical power), this appears to be a reasonable representation of the South Carolina’s 
TB case population from 2005 to 2011, with the exception of age. It is not surprising that 
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our genotyped sample would not be representative in age. As we discussed previously 
pediatric cases are not routinely genotyped because positive cultures on children are very 
difficult to obtain. However, the reasonable similarity between our study sample and our 
entire case population gives us better confidence that our estimate of recent transmission 
of 50.1% is generalizable to 2005 to 2011 South Carolina TB cases. The limitations of 
this estimate will be discussed more in the Limitations of the Study section below. 
Table 8 
 
Summary of Descriptive Statistics for all South Carolina Confirmed Tuberculosis Cases Compared to all 
TB Genotyped Cases, 2005-2011 
 
All Cases 
(N=1,346) 
Genotyped 
Cases 
(N=685) Pearson's R (p-
value) All Cases vs. 
Genotyped Cases 
Clustered 
Cases 
(N=419) 
Variables N % N % N % 
Age 
00-04 69 5.13 3 0.44 3 0.72 
05-14 33 2.45 1 0.15 1 0.24 
15-24 137 10.20 75 10.95 36 8.6 
25-44 385 28.60 215 31.39 135 32.2 
45-64 453 33.70 259 37.81 172 41.1 
65+ 269 20.00 132 19.27 0.985 (< 0.00001) 72 17.2 
Sex at Birth 
Male 863 64.10 463 67.59 286 68.3 
Female 483 35.90 222 32.41 0.992 (0.018) 133 31.7 
Race/Ethnicity 
Black 799 59.36 432 63.07 311 74.2 
Hispanic/Latino 196 14.56 88 12.85 25 6 
Asian American 104 7.73 50 7.3 18 4.3 
White 230 17.09 109 15.91 61 14.6 
Other (American 
Indian, Alaskan Native, 
Native Hawaiian or 
other Pacific Islander) 17 1.26 6 0.87 0.999 (< 0.00001) 4 0.24 
Origin 
US-born 1,061 78.80 545 79.56 379 90.5 
Foreign-born 285 21.20 140 20.44 0.997 (0.003) 40 9.6 
HIV Status 
Negative 1,066 79.20 571 83.36 344 82.1 
(table continues) 
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Positive 103 7.65 60 8.76 41 9.8 
Unknown (Refused, 
Not offered, or 
Missing) 177 13.15 54 7.88 0.993 (< 0.00001) 34 8.1 
Homelessness 
Yes 69 5.04 45 6.57 33 7.9 
No 1,275 93.13 638 93.14 386 92.1 
Unknown 25 1.83 2 0.029 0.997 (< 0.00001) 0 0 
Correctional 
Institution 
Yes 27 2.01 15 2.19 11 2.6 
No 1,319 97.99 670 97.81 0.992 (0.008) 408 97.4 
Alcohol 
Yes 296 21.99 195 28.47 140 33.4 
No 1,038 77.12 485 70.08 275 65.6 
Unknown 12 0.89 5 0.73 0.997 (< 0.00001) 4 0.95 
Illicit Drug Use 
Yes 172 12.80 104 15.18 77 18.6 
No 1,160 86.20 574 83.8 342 81.4 
Unknown 14 1.04 7 1.02 0.997 (< 0.00001) 0 0 
Non-Injection 
Drug Use 
Yes 157 11.66 103 15.04 77 18.4 
No 1,175 87.30 575 83.94 337 80.4 
Unknown 14 1.04 7 1.02 0.997 (< 0.00001) 5 1.2 
Injection Drug 
Use 
Yes 15 1.11 9 1.31 5 1.2 
No 1,317 97.85 669 97.66 409 97.6 
Unknown 14 1.04 7 1.02 0.997 (< 0.00001) 5 1.2 
Previous TB Diagnosis 
 
Yes 59 4.38 29 4.23 23 5.5 
No 1,287 95.62 656 95.77 0.997 (0.003) 296 94.5 
          0.995 (< 0.00001)     
 
Characteristics of Clustered Cases 
Table 9, below, displays the characteristics of non-clustered versus clustered 
cases. For clustered cases, 68% were male, 74% were Black, and over 90% were US-
born. Over 90% were over 25 years old. Just under 6% had a previous TB diagnosis. 
Over 33% were alcohol abusers and about 18% were drug users. Less than 3% were 
(table continues) 
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incarcerated at the time of TB diagnosis. Less than 10% were recently homelessness, and 
less than 10% were HIV positive. Based on the chi-square test results reported in Table 9 
below, clustered cases were statistically more likely to be U.S. born, black, alcohol 
abusers, abusers of non-injection drugs, and of older age. 
Table 9 
 
Characteristics of South Carolina TB Genotype Clustered and Non-Clustered Cases, 2005-2011 
 
N=627, Clustered (n=382), Not Clustered 
(n=245) 
Variables 
Point 
Estimate 
95% 
Wald C.I. Wald Χ2 p-value 
Age 
Child (0 - 14 
years) vs. 
Elderly 
Adult (15 - 64 
years) vs. 
Elderly 
Old (25-
65+years) vs. 
Young (0-24 
years) 1.770 1.09-2.86 5.3454 0.0208 
Sex at Birth 
Male vs. Female 1.060 0.75-1.49 0.106 0.7447 
Race/Ethnicity 
(White = 
reference 
group) 
Black vs. White 2.060 1.29-3.28 51.58 <0.0001 
Hispanic/Latino 
vs. White 0.329 0.18-0.61 18.67 <0.0001 
Other vs. White 0.550 0.28-1.09 2.41 0.121 
Origin 
US-born vs. 
Foreign-born 5.570 3.66-8.47 64.47 <0.0001 
HIV Status 
Positive vs. 
Negative 1.390 0.78-2.50 1.2322 0.267 
Homelessness 
Yes vs. No 2.010 0.99-4.06 3.8052 0.0511 
Correctional 
Institution 
Yes vs. No 1.790 0.56-5.67 0.9666 0.3255 
(table continues) 
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Alcohol 
Yes vs. No 2.030 1.40-2.94 13.93 0.0002 
Illicit Drug Use 
Yes vs. No 2.060 1.28-3.32 8.7344 0.0031 
Non-Injection 
Drug Use 
Yes vs. No 2.150 1.32-3.50 9.5823 0.002 
Injection Drug 
Use 
Yes vs. No 0.799 0.21-3.01 0.1101 0.74 
Substance 
Abuse 
Yes vs. No 2.260 1.30-3.93 8.26 0.004 
Previous TB 
Diagnosis 
Yes vs. No 2.320 0.92-5.83 3.192 0.074 
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Bivariate Analysis 
The second research question asks what are the risk factors for genotype 
clustering among incident South Carolina TB cases from 2005 to 2011? This question 
was first examined with a bivariate unadjusted analysis. As stated previously, the initial 
sample size was 685 genotyped cases. For the purposes of all the logistic analyses, I 
dropped cases for which I did not have complete information on all covariates. There 
were 54 cases with unknown HIV status, 1 of which also had unknown drug and alcohol 
history. There were 2 cases with unknown homeless status, 1 of which also had unknown 
drug history and HIV status, and the other had unknown drug and alcohol history. When 
substracting the cases dropped for unknown homeless history, HIV status, and alcohol 
status there were 2 additional cases with unknown drug status. This resulted in 58 cases 
with missing information that were dropped from our sample giving an analysis sample 
of 627 cases for all logistic models; 382 clustered cases and 245 singleton cases. A 
logistic analysis of the 58 cases dropped for missing data was performed to determine if 
they were more or less likely to be clustered than the cases not dropped. The results of 
this analysis are below in Table 10. No significant association between being dropped 
and being clustered was observed. Thus, we can conclude there was no indication that 
dropped cases were more or less likely to be clustered (or that clustered cases were more 
or less likely to be dropped). 
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Table 10 
 
Dropped Data Analysis 
 
    Not Clustered Clustered   
Not Dropped  Frequency 245 382 627 
Percent 35.8 55.8 91.5 
Dropped Frequency 21 37 58 
Percent 3.1 5.4 8.5 
Total Frequency 266 419 685 
Percent 38.8 61.2 100 
Dropped vs. 
Not Dropped 
Point 
Estimate 95% Wald C.I. Wald Χ2 p-value 
1.130 0.65-2.0 0.184 0.668 
 
 As noted earlier, the age variable was only available in the data as a categorical 
variable (I was not provided date of births in my dataset). Its original categories (as used 
by the RVCT) were 0-4, 5-14, 15-24, 25-44, 45-64, and 65+ years. When the crude model 
of age (in these original categories) and clustering was examined, no associations were 
observed. I decided to collapse the two youngest age groups into 0-15 years as “child” 
because there were so few children in the sample. This was used as the reference group. 
The 3 middle age groups were collapsed into 24-64 years and called “adult”, and 65+ 
years was called “elderly”. With these new classifications, there was still no association 
noted for clustering for either child versus elderly or adult versus elderly. Recall from 
Chapter 2 Literature Review, there was a lot of variation with regard to classification of 
age groups in prior studies, as well as variation in what ages were found to be at risk for 
clustering. Additionally, because my sample had very few children (n = 4) it seemed 
prudent to further collapse these categories to see if any association could be detected with 
larger groups of wider age ranges. Thus, I further collapsed my age categories and tested 
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the bivariate association between risk of clustering and age where “young” was the 
reference group (0-44 years) and old was the risk group (45-65+ years). Table 7 below 
shows that this association was statistically significant with an unadjusted OR of 1.77 
(95% C.I. 1.09-2.86) or people over 44 years old were about 1.8 times more likely to be 
part of a TB genotype cluster than people 44 and younger. 
 The next crude model examined was sex and TB clustering. Although much of the 
literature indicates men may be at higher risk for clustering, no association was observed 
in my population between male sex and risk of clustering, or female sex and risk of 
clustering. Further, neither of these were significantly protective for clustering.  
 The next demographic variable examined was the bridged race/ethnicity variable. 
Although the RVCT does actually inquire about both race and ethnicity as two separate 
questions, the dataset I was provided only contained this information as a bridged variable 
(Meaning the data did not allow me to discern non-Hispanic White or Black persons or 
Hispanic White or Black persons. The only categories available to me were Black, 
Hispanic, Other, and White). When this variable was examined using White as the 
reference group (as is done most often in the literature), people of Black race were 
observed to be at higher risk for clustering with a crude OR of 2.06 (95% C.I. 1.29-3.28). 
Interestingly, Hispanics when compared to Whites displayed a statistically significant 
protective effect for clustering, with a crude OR of 0.33 (95% C.I. 0.18-0.61). Based on 
the finding that Blacks and Whites were at significantly higher risk for clustering when 
compared to Hispanics, I became suspicious there may be an interaction occurring 
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between origin (US-born versus Foreign-born) and race in this population. I explored this 
possibility in the multivariable stage of this analysis discussed in the next section. 
 The next potential predictor variable that was examined was origin classified as 
US-born versus Foreign-born. In the crude analysis, being US-born was highly predictive 
of genotype clustering. Specifically, U.S. born TB cases had over 5.5 times the odds of 
being part of a genotype cluster than did Foreign-born cases in the unadjusted analysis 
(OR = 5.57, 95% C. I. 3.66-8.57). In fact, in the unadjusted analysis US-birth was the 
greatest risk factor for clustering.  
 Next I examined the crude model of HIV status and clustering. Despite what 
previous U.S. studies have observed, the bivariate analysis did not show being HIV 
positive as a risk factor for clustering in this study population. Further, for the crude model 
of living in a correctional facility at the time of diagnosis and clustering, again despite the 
positive association some previous studies have observed, no association was observed in 
my study population. However, being homeless or having been homeless in the year prior 
to diagnosis was significant enough (at an alpha of 0.10) to be included in the multivariate 
stage of the analysis with a crude OR = 2.01, 95% C.I. 0.99-4.06. Additionally, alcohol 
abuse in the year prior to diagnosis was significantly associated with clustering with a 
crude OR of 2.03 (95% C.I. 1.40-2.94). In addition, drug abuse was significantly 
associated with clustering with a crude OR of 2.06 (95% 1.28-3.32). When drug abuse 
was divided into injection drug-users and non-injection drug users, the association 
remained significant only among non-injections drug users, and in fact, it slightly 
increased. I found there was a lot overlap between drug and alcohol users so I decided to 
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combine this into a single covariate called “substance abuse” as has been done in other 
U.S. studies (Moonan, 2012). Substance abuse (alcohol and drug abusers inclusive) 
became an even more significant predictor in the unadjusted model with an OR of 2.26 
(95% C.I. 1.30-3.93) than either alcohol or drug, abuse was alone. Lastly, having had a 
prior diagnosis of TB was significant enough to be included in the multivariate stage of 
the modeling with a crude OR of 2.32 (p-value = 0.074). All bivariate results are 
summarized in Table 11. 
Table 11 
 
Bivariate Analysis of the Association between Tuberculosis Genotype Clustering and Covariates of Interest 
 
N = 627, Clustered (n = 382), Not Clustered (n = 
245) 
Variables 
Point 
Estimate 
95% 
Wald C.I. Wald Χ2 p-value 
Age 
Child (0 - 14 
years) vs. 
Elderly 
Adult (15 - 64 
years) vs. 
Elderly 
Old (25-
65+years) vs. 
Young (0-24 
years) 1.770 1.09-2.86 5.3454 0.0208 
Sex at Birth 
Male vs. 
Female 1.060 0.75-1.49 0.106 0.7447 
Race/Ethnicity 
(White = 
reference 
group) 
Black vs. White 2.060 1.29-3.28 51.58 <0.0001 
Hispanic/Latino 
vs. White 0.329 0.18-0.61 18.67 <0.0001 
Other vs. White 0.550 0.28-1.09 2.41 0.121 
Origin 
US-born vs. 
Foreign-born 5.570 3.66-8.47 64.47 <0.0001 
(table continues) 
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HIV Status 
Positive vs. 
Negative 1.390 0.78-2.50 1.2322 0.267 
Homelessness 
Yes vs. No 2.010 0.99-4.06 3.8052 0.0511 
Correctional 
Institution 
Yes vs. No 1.790 0.56-5.67 0.9666 0.3255 
Alcohol 
Yes vs. No 2.030 1.40-2.94 13.93 0.0002 
Illicit Drug 
Use 
Yes vs. No 2.060 1.28-3.32 8.7344 0.0031 
Non-Injection 
Drug Use 
Yes vs. No 2.150 1.32-3.50 9.5823 0.002 
Injection Drug 
Use 
Yes vs. No 0.799 0.21-3.01 0.1101 0.74 
Substance 
Abuse 
Yes vs. No 2.260 1.30-3.93 8.26 0.004 
Previous TB 
Diagnosis 
Yes vs. No 2.320 0.92-5.83 3.192 0.074 
Statistically significant at alpha <0.05 bivariate association. 
Significant at alpha <0.10, variable examined in the multivariable model. 
Multivariable Analysis 
Additionally, the second research question asks what are the risk factors of 
genotype clustering among incident South Carolina TB cases from 2005 to 2011, when 
controlling for significant covariates? To answer this question a stepwise multivariable 
analysis was performed. The stepwise multiple logistic regression model included all 
covariates that were significant in the bivariate modeling with an alpha of <0.10. These 
were origin, race, age, substance abuse, homelessness, and previous TB diagnosis. HIV 
status, correctional institution, and sex were not included in this stepwise analysis 
because they were not significant in the bivariate analysis. The results of the stepwise 
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multivariable analysis are shown in Tables 12 and 13 below (the full stepwise selection 
process is shown in Appendix B, Table B1). 
Table 12 
 
Odds ratios from the Best-Fit Logistic Regression Analyses of Tuberculosis Genotype Clustering and 
Associated Risk Factors 
 
N=627, Clustered (n=382), Not Clustered (n=245) 
Main Effect 
Odds Ratio Estimates 
(95% C.I.)a Wald Χ2 Wald p-value 
Origin, US-Born vs. 
Foreign-Born 5.67 (2.12% to 15.14%) 11.998 0.0285 
Race, Black vs. White 1.96 (1.26% to 3.14%) 9.060 0.0005 
aWald 95% confidence intervals given in parentheses. Only significant predictors are listed. 
Table 13 
 
Model Fit Statistics from the Best-Fit Logistic Regression Analyses of Tuberculosis 
 
Testing Global Null Hypothesis: BETA=0 
Test Chi-Square DF Pr > ChiSq 
Likelihood Ratio 71.574 1 <.0001 
Score 72.485 1 <.0001 
Wald 64.465 1 <.0001 
Model Convergence Status: Convergence criterion (GCONV=1E-8) satisfied. 
 In the multivariable analysis, the only factors that remained significantly 
predictive for genotype clustering were being U.S. born, and being of Black race. 
Specifically, people US-born were over 5.5 times more likely to be part of a genotype 
cluster than those of foreign birth. People of Black race were almost 2 times more likely 
to be part of a genotype cluster compared to people of White race. As shown in Table 12, 
this final model was a good fit for genotype clustering with a large and significant 
Likelihood Ratio and Wald Score. 
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 As part of the multivariable stage of the analysis, interaction terms were also 
tested. The interaction terms were tested in separate versions of the multivariable model 
where some insignificant covariates were added in order to assess the possibility of 
interaction. The most common method of incorporating an interaction term in a 
multivariable model is to create a product term. I did this by creating a variable whose 
value is the product of two independent variables (i.e., the 2 variables for which I was 
assessing a possible interaction multiplied by each other). Because a product term 
describes the relationship between two risk factors and an outcome, it can only be 
interpreted as an interaction if the two risk factors are in the model. Interaction terms 
were chosen because both of the covariates were significant in the crude model, and/or 
previous research has observed effect modification. The interaction terms that were 
tested were (1) origin and race, (2) origin and previous TB disease, (3) origin and 
substance abuse, (4) origin and HIV status, (5) previous TB disease and race, (6) 
substance abuse and race, and (7) HIV status and race. None of these interaction terms 
was significant in an adjusted model, and they were not included in the final model. 
Please see Table 11 above for the final model. For reference, Appendix B Table B2 
shows the tested models including interaction terms.  
Summary 
 This was a non-experimental, cross-sectional population-based molecular 
epidemiological study of TB in South Carolina from 2005 to 2011. The purpose of the 
study was to estimate the rate of recent TB transmission and investigate the relationship 
between TB genotype clustering and potential risk factors. The data was analyzed using 
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the “n - 1 method” of calculating recent TB transmission and multiple logistic regression 
to examine risk factors for clustering. The results indicated that about 50% of TB in 
South Carolina might be due to recent transmission. Additionally, the study revealed U.S. 
birth and Black race were independently and significantly associated with being part of a 
TB genotype cluster of two or more cases. In Chapter 5, I will further discuss the results 
of the research questions including interpretations, limitations of the study, implications 
for social change, and recommendations for future research. 
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Chapter 5: Conclusions and Recommendations 
 The purpose of this research was to estimate the proportion of South Carolina TB 
that may be due to recently acquired infection, and to determine the risk factors 
associated with the genetic clustering of identical M. tuberculosis isolates. In doing so, 
my objective was to provide suggestions to the South Carolina TB control program 
informed by the molecular epidemiology of TB in the state, as well as to articulate 
recommendations for future research. This was a non-experimental, cross-sectional, 
population-based molecular epidemiological study of TB in South Carolina from 2005 to 
2011. The study population included 685 genotyped TB cases. I answered RQ1 using the 
“n - 1 method” for TB recent transmission estimation, and RQ2 using multiple logistic 
regression analysis to examine the association between TB clustering and predictors. The 
study results strongly suggested that about 50% of TB in South Carolina has been 
recently transmitted. Further, the analysis revealed several associations. The results of the 
bivariate analysis indicated a positive relationship between being U.S. born and genotype 
clustering, being Black and genotype clustering, older age and genotype clustering, being an 
alcoholic and genotype clustering, being a drug abuser and genotype clustering, and being both 
an alcohol and drug abuser and genotype clustering. The bivariate analysis also indicated that 
being Hispanic was protective for genotype clustering. In the multivariable analysis, the only 
factors that remained significantly predictive for genotype clustering were being U.S. born and 
being Black. In the next section, I interpret these findings. 
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Interpretation of Findings 
 Before discussing the research questions individually, I will discuss the results of 
the descriptive statistics performed. The study population (685 genotyped cases) and the 
entire state case population (1,346) were very similar with regard to the covariates of 
interest (see Table 8). Both were mostly adults, and the majority were men. Black was the 
most prevalent race, followed by White, and then by Hispanic and other. For both 
populations, close to 80% of the cases were born in the U.S. Both populations contained less 
than 9% HIV positive, less than 7% homeless, and less than 3% were incarcerated at the 
time of TB diagnosis. About 30% of South Carolina TB cases included in the study reported 
alcohol abuse, compared to about 20% for all TB cases from 2005-2011. The rates of drug 
abuse, particularly injection drug abuse, were low among both populations. For over 95% of 
TB cases in South Carolina this was their first TB diagnosis and this was also true for the 
genotyped cases (i.e., the study population). Chi-square analysis indicated that the study 
population was a reasonable representation of the entire case population of the state 
with the exceptions of that genotyped cases were older, more often alcoholic, and more 
often drug abusers (see Table 8). Particularly, children were underrepresented in the 
study sample (X2 = 46.4, p-value < 0.0001).  
 South Carolina’s estimated rate of recent transmission of about 50% is in 
keeping with previous studies in the southeast U.S., if somewhat higher. Kempf’s 2005 
Alabama study observed a recent transmission rate of 35% (Kempf, 2005). Talarico’s 
2011 Arkansas study did not estimate recent transmission but observed a high clustering 
rate of about 39% (Talarico, 2011). While Weis’s 2002 Tarrant County, Texas, study 
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estimated a rather high recent transmission rate of about 36%, and Moonan’s US-wide 
study estimated a recent transmission rate of about 23% (Weis, 2002, Moonan, 2012). 
In comparison with these previous findings, this study’s estimate of recent transmission 
is higher. The estimate of recent transmission of 50% is outside the range of previous 
studies for low incidence countries with the highest estimate noted from a Southern 
California study of 45% (Rodwell, 2012). If this study’s estimate of 50.2% for recent 
transmission suffers from bias, it is likely biased towards clustering (indicating greater 
recent transmission). This is because the study sample was older, and had more 
substance abuse than the general TB case population. Further, anecdotally, if there was 
any non-random influence for reasons why certain cases might be sent in for genotyping 
(and others not) it could be because contact tracers actually already suspected the case 
was part of an outbreak or cluster. The extent to which this may have resulted in 
sampling bias is unknown. However, even given these assertions, I would conclude that 
50% might be an overestimate of recent transmission, there is good analytical reason to 
believe South Carolina’s rate of recent transmission is very high. If I calculate a range 
of recent transmission based on the entire denominator of 1,346 confirmed cases we 
would still have a recent transmission rate of 25.5 % (343/1346) at the lowest; and this 
would be assuming no other cases in the state were clustered which is a rather far-
fetched assumption. In reality, the recent transmission rate likely lies somewhere 
between 25.5 to 50.2%. This means that a staggering 1 to 2 out of every four cases of 
TB in South Carolina are due to recent transmission. This is quite substantial for a 
wealthy First World country with a low incidence of TB overall. Some European and 
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U.S. studies observed similar findings. An English study from 1998 showed a 52% rate 
of clustering and 40% rate of recent transmission; a national study carried out in the 
Netherlands during 1993–1997 found estimates for clustering and recent transmission of 
46% and 35%, respectively; and a study of 7 sentinel surveillance sites in the USA 
during 1996–2000 estimated clustering at 48%; and a cross-sectional study during 
2005–2009 estimated recent transmission as 23%, (Love, 2009; Moonan, 2012; Ellis, 
2002; van Soolingen, 1999).  
 With regard to risk factors for clustering, the results of this study are fairly 
consistent with what has been observed in prior U.S. studies. Almost all U.S. studies 
have found U.S. birth to be an independent predictor for clustering. US-born persons 
would have had more time in the U.S. to have acquired and spread TB to their contacts, 
than recently arrived immigrants. Additionally, it does make sense that infected persons 
born outside of the U.S. might be more likely to have acquired TB in their country of 
origin, as the U.S. has a relatively low incidence of TB compared to much of the 
developing world. Further, U.S. physicians may be more likely to recognize TB 
symptoms and test for TB in immigrants from the developing world than in native U.S. 
persons. Thus, foreign-born persons may be more likely to have a singleton genotype if 
their TB is diagnosed early after arrival, whereas U.S. cases may go unrecognized 
longer allowing for more spread prior to intervention. To summarize foreign-born 
persons are more likely to have acquired their TB natively within a genotype cluster in 
their country of origin and may or may not propagate that cluster once they immigrate. 
Therefore, this finding is consistent and makes sense. 
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 Almost all U.S. studies have observed Black race to be independently predictive 
of TB clustering and a few European studies have as well (Barnes, 1997; Cattamanchi, 
2006; Ellis, 2006; Kempf, 2005; Cacho-Calvo, 2005). Importantly, 63% of the study 
population and 59% of South Carolina TB cases overall are of Black race, even though 
only about 30% of South Carolina’s population is Black. Because TB disproportionately 
affects Black South Carolinians, this finding, while not surprising, is important. It 
would appear that in South Carolina, Black people are at much higher risk for TB 
transmission than other races. It is difficult to know if the risks Black people face are 
due to factors other than race. Because TB is a highly contagious, airborne disease for 
which close family contacts would be at risk, certainly, familial clusters will usually 
include a racial component as people that are biologically related to each other are 
likely to be of the same race. However, the literature indicates the higher risks 
experienced by Black people are almost certainly environmental (Kempf, 2005; 
Talarico, 2011; Weis, 2002). Recall this study’s final model controlled for some 
environmental factors such as substance abuse, homelessness, origin, and a previous TB 
diagnosis; and Black race remained highly significant. Some hypotheses that have been 
presented in other studies include that southern Black Americans are adverse to the 
public health system because of past segregation, institutional racism, and an overall 
perception of mistrust (Mays, 2012; Mays, 2017; Wechkunanukul, 2016). This mistrust 
perception in people of Black race may result in being reluctant to seek diagnosis and 
treatment. Further when diagnosed, people of black race maybe less forthcoming to 
public health investigators regarding contacts, and well as contacts might be harder to 
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find and follow if they are attempting to avoid the government-based public health 
sector.  
 Unfortunately, this study was not able to access socioeconomic factors that may 
also play a role in the increased risk for people of Black race and TB clustering. 
Differences in the uninsured populations of Black and whites may certainly effect 
access to care and result in treatment and diagnosis delays causing higher rates of TB 
transmission, thus clustering. For Black people, the likelihood of being uninsured varies 
widely across states, however, uninsured rates for nonelderly Blacks are particularly 
high in the South. The uninsured rate for nonelderly Black people in South Carolina is 
between 23 and 30% (Duckett, 2013). In the US, Blacks are significantly more likely 
than Whites to be uninsured with more than 1 in 5 (21%) nonelderly Blacks uninsured, 
compared to 13% of their White counterparts (Duckett, 2013). Future research is needed 
to determine the reason or combination of reasons southern Black Americans are 
disproportionately affected by TB and how best to address these reasons. 
 Unlike my study, several U.S. studies have observed either alcohol, drug abuse, 
or all substance abuse as independently predictive for clustering. In an Arkansas, study 
(Talarico, 2011) rates of clustering were 19.8% among those with a history of alcohol 
abuse versus 8.6% among those without (p-value < 0.0001). Moonan’s comprehensive 
US-wide study, noted earlier, also found a strong association between clustering and 
being more likely to abuse substances with an aOR of 1.4 (99% C.I. 1.3-1.7), where 
substance abuse was any abuse of drugs or alcohol (2012). In this study, substance 
abuse was significant in the bivariate model, and 33% of clustered cases were alcohol 
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abusers compared to only 20% of non-clustered cases. While 18% of clustered cases 
were drug, abusers compared to only 10% of non-clustered cases. As discussed earlier, 
my study sample was statistically different from the South Carolina case population 
with regard to alcohol and drug abuse. Alcoholic and drug addicts were overrepresented 
in the study sample, which may explain some of this perceived association; however, it 
is not likely to explain all of it. Importantly, recall from Chapter 2 that persons with 
substance abuse may be at greater risk for clustering for a number of reasons. They may 
(1) congregate closely in social settings such as bars (2) have poor recall of social 
contacts and events, thus are not able to provide a comprehensive contact list to public 
health investigators delaying or preventing PEP initiation, (2) have unknown, thus 
uncontrolled for co-morbidities that increase their vulnerability for disease as well as 
decrease the time they progress from infection to disease, or (3) be more prone to 
treatment non-adherence due to the interaction of alcohol and common TB drugs, (5) 
have poor nutrition and other substance abuse related health issues (6) persons who 
abuse alcohol, crack cocaine, heroin, marijuana, and methamphetamines have all been 
shown to experience significant weakening to one or more important immunologic 
mechanisms (Gamble, 2006; Baldwin, 1997; Lysle, 2000; Tashkin, 2002; Friedman, 
2003; Mahajan, 2006) (7) substance abuse occurs in enclosed spaces with intentionally 
limited or poor ventilation and high volumes of human traffic likely increasing the odds 
of TB transmission (Oeltmann, 2006; Oeltmann, 2009), and (8) previous research has 
noted that persons who abuse substances are less likely to seek treatment resulting in an 
extended period of infectiousness and advanced disease at diagnosis (CDC, 2003). It 
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seems likely that contact tracing in these groups may not be as effective, leading to 
ongoing transmission. 
 In this study there were a few interesting findings that are somewhat inconsistent 
compared with prior research. First, current incarceration was not found to be associated 
with clustering. Recall that Kempf’s Alabama study observed an aOR of 2.9 (95% 
C.I.1.3- 6.6) (2005) for the association of clustering and residence in a correctional 
facility in the year prior to diagnosis. However, in contrast, Moonan’s U.S. wide 
population-based study did not observe an association with residence in a correctional 
facility at the time of diagnosis (aOR 0.8; 99% C.I. 0.7-1.0) (2012). Moonan’s and this 
study likely had similar results (contrasting with Alabama’s) regarding incarceration 
because our studies assessed only current incarceration, not prior or recent. This might 
suggest that the risk of TB transmission in incarceration settings may be more often due 
to short term stays in jails where TB often goes undiagnosed and untreated. Then the 
inmate is put back on the street to spread TB, where he or she might finally be 
diagnosed by the public health surveillance system.  
 Next, HIV status was not observed to be a significant predictor in my study as it 
has in a few prior U.S. studies (Ellis, 1994; Talarico, 2011; Moonan, 2012). This could 
be for a number of reasons. First, there were very few HIV positive individuals in my 
study population and this, coupled with the fact that there were many individuals in my 
study population that had to be dropped from analysis due to unknown HIV status 
(recall this was the primary variable which necessitated dropping cases), these low 
numbers substantially decreased my power in both the bivariate and multivariate 
112 
 
 
analysis to reveal an effect, if, in fact, one exists. Further, it is not inconceivable that 
people who refuse HIV testing do so because they have multiple HIV risk factors, or in 
fact, already know they are positive and do not share those results. This could have 
biased the findings. Also, this study had contained no information regarding immune-
competence of any HIV positive individual. Thus, an HIV positive person that is 
receiving HIV therapy with adequate immune-competence may not be at a noticeably 
increased risk of being part of a TB cluster. 
Limitations of Study 
 A few limitations should be noted that affect the interpretation of the findings and 
the generalizability of my results. First, my study was limited to those confirmed TB 
cases for which a valid TB genotype could be obtained. As discussed at length in Chapter 
3, generally cases that are exclusively extrapulmonary (those are TB cases that have only 
extrapulmonary disease rather than both pulmonary and extrapulmonary) are confirmed 
via some other testing methodology such as a PCR instead of culture, thus there is not 
culture to genotype. This was true with the exception of extrapulmonary cases that are of 
the pleural space of the lungs, which are usually confirmed, similar to pulmonary cases 
using sputum specimen cultures. Another reason a case may have been considered 
ineligible for culture was the age of the patient. Patients, ages between 5 and 12 years, are 
difficult to obtain a positive culture from and cultures are often not attempted or used for 
confirmation. Once those confirmed cases considered “ineligible” for genotype were 
excluded only 1,080 of the 1,346 TB cases in South Carolina from 2005-2011 were eligible 
for genotype. Of these, 685 were successfully genotyped. The other cases were not 
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genotyped for a variety of reasons including a culture was not obtained because the patient 
was lost to follow-up, the patient had a negative culture but was confirmed via some other 
combination of tests or symptoms, or the diagnosing laboratory simply did not send their 
TB isolates to the National TB lab for genotyping. Thus, only 50.9% (685/1,346) of all TB 
confirmed cases were genotyped. The 49.1% of confirmed incident cases that were not 
genotyped may have differed from the 685 incident TB cases in important ways that may 
have biased my results. However, I was able to use publically available descriptive data on 
the TB incident case population of South Carolina from 2005 to 2011 to compare with my 
fully genotyped sample on all the covariates examined in my study. This information was 
available through an intranet query site called the CDC’s Online Tuberculosis Information 
System (OTIS) that provides data in 5-year aggregate summary totals by state (CDC, 
2016). From this, I was able to determine how alike or different my sample was from the 
entire sampling frame in at least a few characteristics (see Table 8). In addition, this 
limitation also represents an opportunity. There was a high proportion (43%) of TB cases 
without a culture, and therefore, not genotyped. This is an opportunity to emphasize the 
importance of comprehensive TB case genotyping, in order to fully characterize the 
molecular epidemiology of TB in any jurisdiction or geography. This is discussed further 
in the Recommendations section of this chapter. 
This second limitation of this study was that it was limited in place and time, in 
that I am only able to examine genotypes of cases diagnosed within South Carolina 
between 2005 and 2011. Cases diagnosed outside of this time period (either before or 
after) within South Carolina, cases diagnosed within this time period but outside of 
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South Carolina, and cases diagnosed outside this time period (either before or after) and 
outside of South Carolina will not be included in this study. This means that TB chains 
of transmission beyond the geographic and time boundaries set in this study cannot be 
investigated. Certainly, this is a common limitation of all molecular epidemiological 
studies, as researchers will always be limited by the data they collect or, as in the case 
of this study, that which was secondarily available to them. However, because TB 
transmission recognizes no time or geographical boundaries, this will have implications 
for the conclusions that may be drawn from study’s findings. These implications are 
explored in the Conclusions, Chapter 5, of this research.  
A third limitation of this study was that for the purposes of answering Research 
Question 1(b) what proportion of TB in South Carolina may be due to recent 
transmission?. To answer this question epidemiological information (dates of onset, 
diagnosis, etc.) was not reviewed. This determination was a mathematical calculaton in 
order to provide a reasonable indication of the proportion of South Carolina TB cases 
that may be due to recent transmission. The epidemiological assertion is based on recent 
transmission index of (RTI) i.e., RTIn-1 = (nc - c)/n, in which n is the total number of 
the studied cases, nc is the total number of cases in cluster (size 2 or greater) and c is the 
number of genotypes represented by at least two cases. Based on this index, patients in 
cluster are considered as recent transmission and non-cluster cases are considered as 
reactivation. This index also has been referred to as the “n - 1 method.” In depth review 
of source medical records to determine true source cases for comparison to the 
mathematically calculated determination were not the approach of this study for two 
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reasons. First, because the time it takes latent TB infection to manifest to disease varies 
widely as it was often a result of both known and unknown host factors, dates of onset 
and diagnosis obtained may not be helpful or reliable in determing source or index cases 
for clusters or outbreaks. Second, most TB population-based molecular epidemiological 
studies do not use medial record review to determine the proportion of recent 
transmission, but do it mathematically in just the way I have outlined in Research 
Question 1(b). This was an exceptible limitation because the methods used in this study 
were consistent with previous research making my research comparable to other studies 
of this nature. 
Recommendations 
 The findings revealed that a considerable portion of TB in South Carolina was due 
to recent transmission, and U.S. birth and Black race were independently and significantly 
associated with being part of a TB genotype cluster of two or more cases. While incident 
cases of TB have decreased in South Carolina over the previous 8 years, going from 261 
cases reported in 2005 to 140 cases reported (South Carolina DHEC, 2014), South 
Carolina still had the 15th highest case rate in the U.S. with 3 cases per 100,000 people 
(CDC, 2013). TB is a significant public health problem in South Carolina, it is with that 
in mind this study was undertook, and recommendations are made. While South 
Carolina has a relatively low incidence of TB, in general it does appear that most of 
their TB is due to recent transmission, not importation or reactivation; thus happening 
well within the purview of the United States’ seemingly robust health care system. This 
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indicates that opportunities for prevention and interruption of the chain of transmission 
are being missed. 
 Based on the process and results of this study, I would make several specific 
recommendations to the South Carolina TB Control Program.  
1. From 2005-2011, 37% of eligible TB cases in South Carolina did not have a 
genotyped culture and 49.1% of all TB cases did not have a genotyped culture. The 
proportion of cases in South Carolina being genotyped is too low. While it is difficult 
to obtain a culture on all TB cases for a variety of reasons (reasons discussed at 
length in earlier chapters), every effort should be made at the local and state level to 
make this happen. Every TB case should be confirmed with a culture and every 
culture should be genotyped, especially children. Understandably, children are 
difficult on which to obtain cultures, but they are also the most important. Because 
children progress quickly for TB infection to TB disease, they might be sentinel 
cases in a TB cluster or outbreak. Further, TB in children is usually an indication of 
new and ongoing transmission. Confirming pediatric cases with a culture and 
knowing their genotypes early is of the utmost importance. Health department staff 
should follow-up with private sector providers and labs to make sure cultures are 
sent in for genotyping. There are important reasons to obtain a genotype on every 
case that go well beyond having complete research data. They include: 
a. identification or confirmation of outbreaks, 
b. identification of locations at which transmission occurs, 
c. identification of characteristics of TB disseminators, 
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d. characteristics of people at increased risk for acquiring TB infection and 
for rapid progression to TB, 
e. detection of unsuspected transmission, 
f. determination of the potential for reinfection, 
g. detection of laboratory cross-contamination and 
h. evaluation of TB control activities designed to prevent transmission. 
2. The TB case record and accompanying RVCT is not a static document, it should be 
continuously updated as new information is revealed. While the issue of missing data 
was not a problem in this study, it was apparent in data review that some patient 
characteristics were much less complete than those examined by this study. For 
instance, patient employer/occupation contained many unknown/missing data. In 
addition, the question of whether antibiotic susceptibilities were performed, and the 
associated results of those susceptibilities also contained a lot of unknown/missing 
information. Having more complete case records is important for conducting formal 
studies such as this one, as well as evaluating the effectiveness of prevention and 
control efforts. 
3. In South Carolina, measures should be implemented to address the staggering racial 
disparity in TB disease. This will be daunting task, but should begin with a few 
initial steps. First, the racial and ethnic makeup of the DHEC TB control staff should 
better reflect the TB case population. Additionally, language, ethnic, cultural, and 
economic barriers should not be obstacles to prevent thorough case and contact 
investigations. Community partners may be enlisted such as churches and 
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community health centers. Where there have been other areas of public health 
success in addressing racial disparities such as diabetes education, smoking cessation 
promotion, and HIV control and prevention, determine if there are opportunities for 
TB education to piggyback off some of these efforts. 
4. While substance abuse was not significant in the final model, this study revealed that 
substance abusers were clustered more than not. Alcohol and drug environments are 
likely places where TB is being spread. Drinking and drugging acquaintances should 
not be overlooked in contact investigations. Understandably, a cases’ addiction 
behavior is a sensitive topic of discussion however, contact tracers should repeatedly 
query it. 
5. While recent homelessness was only a significant predictor in the crude model, 
homeless shelters or camps might also be places where TB is being spread. Street 
friends, “couch surfing” contacts, and other transient living environments should be 
investigated thoroughly. Homeless adults and unemployed adults stating they have 
estranged family or no family should not be assumed to have no contacts.  
6. HIV status was not a significant predictor of TB clustering in this study population. 
However, HIV status was unknown 8% of these cases. It is important that every TB 
case be offered and strongly encouraged to take an HIV test. Further, contacts to 
infectious TB cases should be tested for HIV in order to prioritize them for 
treatment. 
7. Contact investigations must move beyond the traditional approach. Typically, the 
South Carolina TB Control Program uses the concentric circle approach to prioritize 
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contact investigations. Several studies have shown the concentric circle method often 
misses peripheral, yet high risk contacts (Moro, 2002, Izumi, 2015, Feske, 2011, 
Driver, 2006). This is probably resulting in contacts and cases being missed. 
Alternatives to the traditional contact investigation should be piloted in South 
Carolina. This could include social network contact tracing, or activity-space-
contact-tracing. 
8. “Lost to follow-up” status is unacceptable for TB cases. Because TB is a highly 
infectious and, when untreated, a sometimes-fatal disease, all efforts should be made 
to avoid losing any case for follow-up and treatment. 
The current study reveals several opportunities for future research. A southeast U.S. study 
with better representation among children is needed. More research is needed to flesh out the 
relationship between race and genotype clustering. Specifically, studies need to be conducted 
to identify the root causes for the racial disparities in TB disease. More research is needed to 
better understand if there is a relationship between being HIV positive and being part of a TB 
cluster. A study with complete information on co-morbidities such as diabetes, COPD, and 
smoking may help present a more complete model for risk of TB clustering as certain co-
morbidities that increase the risk of disease progression. Studies or pilot programs 
investigating alternatives to the traditional contact investigation should be implemented. A 
South Carolina study similar to a Tokyo study by Izumi and colleagues whose aim was to 
identify possible tuberculosis hotspots using TB genotype clustering statuses and the concept 
of "activity space", which is a place where patients spend most of their waking hours might be 
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very informative for determining where to target control efforts (Izumi, 2015). Also, a study 
using Social Network Analysis might be indicated. 
Implications for Social Change 
 As stated previously, the goal of the research was to estimate the proportion of 
South Carolina TB that may be due to recently acquired infection, and determine the risk 
factors associated with the genetic clustering of identical M. tuberculosis isolates. The 
research performed was able to answer the research questions and provide insight into the 
previously unknown transmission dynamics and molecular epidemiology of TB in South 
Carolina. The study findings provide opportunities for social change. The 
recommendation section above provides useful information for TB services and policy 
makers to help identify where resources may be best deployed. 
 The relationships revealed indicate more could be done to interrupt the TB chain 
of transmission at the individual and local level. At the individual level as part of the 
positive social change implications of this research it is my hope that cases that would 
have been missed when investigated with traditional contact investigation alone, will be 
discovered when employing targeted contact investigation informed by the findings of 
this study. At the organizational level, genotyping may facilitate quicker confirmation 
of known contacts, detection of unknown contacts, or revelation of transmission 
environments (Malakmadze, 2006; Yeo, 2006). If a jurisdiction participates in the U.S. 
national TB genotyping program, consistently sends all their confirmed case specimens 
in for genotyping, and checks those results frequently they may find linked cases that 
their standard contact investigations did not reveal. In addition, TB contact tracers may 
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confirm suspected epidemiological links they were already investigating. This approach 
may help a jurisdiction make decisions about how aggressive and widespread their 
contact investigations should or should not be, where to focus limited resources, and if 
there are transmission environments traditional contact investigations are missing. 
Targeted contact-investigation informed by TB genotype results could result in an 
overall cost-savings to the South Carolina TB Control Program and similar programs.  
 At the societal level, the social change implication is that it might facilitate 
reaching the U.S. TB elimination goals by informing the South Carolina TB Control 
Program and potentially other states’ control efforts, particularly states with similar 
populations and public health resources as that of South Carolina. As discussed in the 
recommendations section above, the study’s findings provide a platform for future 
research. This research could lead to better TB control efforts that result in an 
interruption in the chain of transmission and resulting in fewer TB infections. This 
would bring the U.S. one-step closer to TB elimination.  
Conclusion 
The purpose of this research was to estimate the proportion of South Carolina TB 
that may be due to recently acquired infection, and determine the risk factors associated 
with the genetic clustering of identical M. tuberculosis isolates. The results indicated that 
a considerable portion of TB in South Carolina was due to recent transmission. 
Additionally, the results showed U.S. birth and being of Black race were independently 
and significantly associated with being part of a TB genotype cluster of two or more 
cases. The key messages of this study are (a) a substantial portion of TB in South 
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Carolina is due to recent transmission not reactivation or importation, and (b) 
transmission of TB in South Carolina occurs in groups often defined by American origin, 
and Black race. These important points reveal one important conclusion; most TB in 
South Carolina is preventable. Because the global and domestic impact of TB disease is 
substantial with global incidence by recent estimates nearly 9.6 million people, and in the 
U.S. between 500 and 600 people dying every year from TB (WHO, 2016), TB 
elimination is an important public health goal. TB although an ancient plague is now 
preventable, treatable, and curable. TB elimination in the developed world is within 
reach. 
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Appendix B: Analysis Process Tables 
 
 
Table B1 
 
Full Stepwise Procedure for Final Model Selection for the Relationship between Tuberculosis Genotype 
Clustering and Risk Factors 
 
The LOGISTIC 
Procedure 
              
Model 
Information 
Data Set OUT.TBGENO3 
Response 
Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
       
Stepwise 
Selection 
Procedure 
       
Class Level 
Information 
Class Value 
Design 
Variables 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
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Substance Abuse Yes 1 
No -1 
Homelessness Yes 1 
No -1 
Previous TB 
Disease Yes 1 
No -1 
Age Old 1 
Young -1 
Origin US-Born 1 
Foreign-Born -1 
Step 0. Intercept 
entered:        
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
-2 Log L = 839.029 
Residual Chi-
Square Test 
Chi-Square DF Pr > ChiSq 
86.5728 8 <.0001 
Step 1. Effect 
Origin entered:        
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept 
and 
Covariates 
AIC 841.029 771.455 
SC 845.47 780.337 
-2 Log L 839.029 767.455 
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Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 71.5741 1 <.0001 
Score 72.4848 1 <.0001 
Wald 64.4654 1 <.0001 
Residual Chi-
Square Test 
Chi-Square DF Pr > ChiSq 
15.902 7 0.026 
Note: No effects 
for the model in 
Step 1 are 
removed. 
       
Step 2. Effect 
Race entered:        
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept 
and 
Covariates 
AIC 841.029 768.57 
SC 845.47 790.775 
-2 Log L 839.029 758.57 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 80.4593 4 <.0001 
Score 80.6662 4 <.0001 
Wald 71.4186 4 <.0001 
Residual Chi-
Square Test 
Chi-Square DF Pr > ChiSq 
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6.7964 4 0.147 
Note: No effects 
for the model in 
Step 2 are 
removed. 
       
Note: No 
(additional) 
effects met the 
0.05 significance 
level for entry 
into the model. 
       
Summary of 
Stepwise 
Selection 
Step Effect Entered Removed DF 
Number 
In 
Score 
Chi-
Square 
Wald 
Chi-
Square 
Pr > 
ChiSq 
1 Origin 1 1 72.485 <.0001 
2 Race 3 2 9.2341 0.026 
Type 3 Analysis 
of Effects 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Race 3 9.0604 0.0285 
Origin 1 11.9979 0.0005 
Analysis of 
Maximum 
Likelihood Est.s 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 -0.1045 0.114 0.8395 0.36 
Race Other 1 0.3425 0.313 1.1974 0.274 
Hispanic/Latino 1 -0.0617 0.3098 0.0396 0.842 
Black 1 0.1968 0.263 0.56 0.454 
Origin US-Born 1 0.8676 0.2505 11.998 5E-04 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 
Confidence 
Limits 
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Race Other vs. 
White 2.271 0.764 6.749 
Race 
Hispanic/Latino 
vs. White 1.516 0.514 4.473 
Race Black vs. 
White 1.963 1.225 3.144 
Origin US-Born 
vs. Foreign-Born 5.67 2.124 15.136 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 49.5 Somers' D 0.354 
Percent 
Discordant 14.1 Gamma 0.557 
Percent Tied 36.4 Tau-a 0.169 
Pairs 93590 c 0.677         
 
 
Table B2 
 
All (7) Multivariable Logistic Regression Models including Interaction Terms for the Relationship between 
Tuberculosis Genotype Clustering and Covariates of Interest 
1. The LOGISTIC 
Procedure Testing 
the Origin and 
Race Interaction 
Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
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Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
Origin US-Born 1 
Foreign-Born -1 
Model 
Convergence 
Status 
Quasi-complete 
separation of data 
points detected. 
Warning: The 
maximum 
likelihood 
estimate may not 
exist. 
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Warning: The 
LOGISTIC 
procedure 
continues in spite 
of the above 
warning. Results 
shown are based 
on the last 
maximum 
likelihood 
iteration. Validity 
of the model fit is 
questionable. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 766.743 
SC 845.47 802.271 
-2 Log L 839.029 750.743 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 88.2858 7 <.001 
Score 85.8964 7 <.001 
Wald 66.4608 7 <.001 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Race 3 2.727 0.4357 
Origin 1 0.003 0.9564 
Race*Origin 3 1.4567 0.6923 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. 
Standard 
Error 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 
-
3.30 68.198 0.0023 0.961 
Race Other 1 3.53 68.199 0.0027 0.958 
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Race Hispanic/Latino 1 2.50 68.199 0.0013 0.970 
Race Black 1 
-
2.85 152.5 0.0004 0.985 
Origin US-Born 1 3.72 68.198 0.003 0.956 
Race*Origin Other US-Born 1 2.86 68.199 0.0018 0.9665 
Race*Origin Hispanic/Latino US-Born 1 3.62 68.199 0.0028 0.957 
Race*Origin Black US-Born 1 3.40 152.5 0.0005 0.982 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 49.7 Somers' D 0.359 
Percent 
Discordant 13.8 Gamma 0.565 
Percent Tied 36.4 Tau-a 0.171 
Pairs 93590 c 0.679         
2. The LOGISTIC 
Procedure Testing 
the Origin and 
Previous TB 
Disease 
Interaction Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
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Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Origin US-Born 1 
Foreign-Born -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
Previous TB 
Diagnosis Yes 1 
No -1 
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 768.721 
SC 845.47 799.808 
-2 Log L 839.029 754.721 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
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Likelihood Ratio 84.3077 6 <.001 
Score 83.7743 6 <.001 
Wald 73.3824 6 <.001 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Origin 1 6.7536 0.009 
Race 3 8.5973 0.035 
Previous TB 
Diagnosis 1 2.8822 0.089 
Origin*Previous 
TB Diagnosis 1 0.0238 0.877 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
P > 
ChiSq 
Intercept 1 0.30 0.266 1.3287 0.249 
Origin US-Born 1 0.91 0.3536 6.7536 0.009 
Race Other 1 0.32 0.3146 1.0498 0.305 
Race Hispanic/Latino 1 0.03 0.3111 0.0133 0.908 
Race Black 1 0.19 0.2632 0.5248 0.468 
Previous TB 
Diagnosis Yes 1 0.45 0.2651 2.8822 0.089 
Origin*Previous 
TB Diagnosis US-Born Yes 1 0.04 0.2653 0.0238 0.877 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
Race Other vs. 
White 2.224 0.746 6.632 
Race 
Hispanic/Latino 
vs. White 1.555 0.526 4.598 
Race Black vs. 
White 1.95 1.215 3.128 
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Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 51.5 Somers' D 0.367 
Percent 
Discordant 14.8 Gamma 0.554 
Percent Tied 33.8 Tau-a 0.175 
Pairs 93590 c 0.683 
                
3. The LOGISTIC 
Procedure Testing 
the Origin and 
Substance Abuse 
Interaction Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
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Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Origin US-Born 1 
Foreign-Born -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
Substance Abuse Yes 1 
No -1 
Model 
Convergence 
Status 
Quasi-complete 
separation of data 
points detected. 
Warning: The 
maximum 
likelihood 
estimate may not 
exist. 
Warning: The 
LOGISTIC 
procedure 
continues in spite 
of the above 
warning. Results 
shown are based 
on the last 
maximum 
likelihood 
iteration. Validity 
of the model fit is 
questionable. 
Model Fit 
Statistics 
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Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 769.954 
SC 845.47 801.041 
-2 Log L 839.029 755.954 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 83.0747 6 <.001 
Score 82.6179 6 <.001 
Wald 71.8622 6 <.001 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Origin 1 0.001 0.974 
Substance Abuse 1 0.0005 0.981 
Race 3 8.3197 0.039 
Origin*Substance 
Abuse 1 0.0006 0.980 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 
-
2.84 117 0.0006 0.980 
Origin US-Born 1 3.77 117 0.001 0.974 
Substance Abuse Yes 1 2.71 117 0.0005 0.981 
Race Other 1 0.35 0.3129 1.2741 0.259 
Race Hispanic/Latino 1 0.03 0.3102 0.0137 0.9067 
Race Black 1 0.16 0.2638 0.3886 0.533 
Origin*Substance 
Abuse US-Born Yes 1 2.92 117 0.0006 0.980 
Odds Ratio 
Estimates 
157 
 
 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
Race Other vs. 
White 2.303 0.775 6.845 
Race 
Hispanic/Latino 
vs. White 1.56 0.528 4.608 
Race Black vs. 
White 1.907 1.188 3.062 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 54.9 Somers' D 0.37 
Percent 
Discordant 17.9 Gamma 0.508 
Percent Tied 27.2 Tau-a 0.176 
Pairs 93590 c 0.685         
4. The LOGISTIC 
Procedure Testing 
the Origin and 
HIV Status 
Interaction Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
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Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Origin US-Born 1 
Foreign-Born -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
HIV Status Yes 1 
No -1 
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 772.388 
SC 845.47 803.475 
-2 Log L 839.029 758.388 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
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Likelihood Ratio 80.6409 6 <.000 
Score 80.8195 6 <.000 
Wald 71.536 6 <.000 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Origin 1 7.6033 0.005 
HIV Status 1 0.0589 0.808 
Race 3 8.8275 0.031 
Origin*HIV 
Status 1 0.0033 0.954 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 0.05 0.2409 0.0516 0.820 
Origin US-Born 1 0.87 0.3187 7.6033 0.005 
HIV Status Yes 1 0.05 0.2346 0.0589 0.808 
Race Other 1 0.34 0.3161 1.2119 0.271 
Race Hispanic/Latino 1 
-
0.06 0.3103 0.043 0.835 
Race Black 1 0.19 0.2638 0.5232 0.469 
Origin*HIV 
Status US-Born Yes 1 0.01 0.2339 0.0033 0.954 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
Race Other vs. 
White 2.276 0.761 6.805 
Race 
Hispanic/Latino 
vs. White 1.507 0.51 4.45 
Race Black vs. 
White 1.945 1.212 3.121 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
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Percent 
Concordant 53.2 Somers' D 0.363 
Percent 
Discordant 17 Gamma 0.517 
Percent Tied 29.8 Tau-a 0.173 
Pairs 93590 c 0.681         
5. The LOGISTIC 
Procedure Testing 
the Previous TB 
Diagnosis and 
Race Interaction 
Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Origin US-Born 1 
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Foreign-Born -1 
Previous TB 
Diagnosis Yes 1 
No -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 772.43 
SC 845.47 812.398 
-2 Log L 839.029 754.43 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 84.5996 8 <.001 
Score 83.8672 8 <.001 
Wald 73.1044 8 <.001 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Race 3 2.0279 0.566 
Origin 1 12.1922 0.001 
Previous TB 
Diagnosis 1 2.1003 0.147 
Previous TB 
Diagnosis*Race 3 0.3187 0.956 
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Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 0.27 0.2873 0.9274 0.335 
Race Other 1 0.25 0.5204 0.2441 0.621 
Race Hispanic/Latino 1 0.06 0.6315 0.0119 0.913 
Race Black 1 0.34 0.4589 0.5673 0.451 
Origin US-Born 1 0.87 0.2514 12.192 0.000 
Previous TB 
Diagnosis Yes 1 0.41 0.2873 2.1003 0.147 
Previous TB 
Diagnosis*Race Yes Other 1 
-
0.07 0.4685 0.0239 0.877 
Previous TB 
Diagnosis*Race Yes Hispanic/Latino 1 0.11 0.5833 0.0394 0.842 
Previous TB 
Diagnosis*Race Yes Black 1 0.16 0.3932 0.1714 0.678 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
Origin US-Born 
vs. Foreign-Born 5.788 2.16 15.50 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 51.5 Somers' D 0.368 
Percent 
Discordant 14.7 Gamma 0.556 
Percent Tied 33.8 Tau-a 0.176 
Pairs 93590 c 0.684         
163 
 
 
6. The LOGISTIC 
Procedure Testing 
the Substance 
Abuse and Race 
Interaction Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Substance Abuse Yes 1 
No -1 
Origin US-Born 1 
Foreign-Born -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
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Black 0 0 1 
White -1 -1 -1 
Model 
Convergence 
Status 
Quasi-complete 
separation of data 
points detected. 
Warning: The 
maximum 
likelihood 
estimate may not 
exist. 
Warning: The 
LOGISTIC 
procedure 
continues in spite 
of the above 
warning. Results 
shown are based 
on the last 
maximum 
likelihood 
iteration. Validity 
of the model fit is 
questionable. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 771.567 
SC 845.47 807.095 
-2 Log L 839.029 755.567 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 83.462 7 <.001 
Score 83.0868 7 <.001 
Wald 72.3752 7 <.001 
Joint Tests 
165 
 
 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
Substance Abuse 1 1.1265 0.288 
Origin 1 11.5907 0.001 
Race 3 1.2116 0.750 
Substance 
Abuse*Race 2 0.3685 0.832 
Substance Abuse 
Yes Race Black = 
Intercept + 
Substance Abuse 
Yes + 3 * Race 
Other - Race 
Hispanic/Latino 
- Race Black + 3 
* Substance 
Abuse Yes Race 
Other - 
Substance Abuse 
Yes Race 
Hispanic/Latino 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 0.03 0.1871 0.0415 0.838 
Substance Abuse Yes 1 0.16 0.1587 1.1265 0.288 
Origin US-Born 1 0.85 0.2508 11.590 0.000 
Race Other 1 5.39 141.9 0.0014 0.969 
Race Hispanic/Latino 1 5.34 141.9 0.0014 0.97 
Race Black 1 0.18 0.2655 0.474 0.491 
Substance 
Abuse*Race Yes Other 1 5.03 141.9 0.0013 0.971 
Substance 
Abuse*Race Yes Hispanic/Latino 1 
-
5.30 141.9 0.0014 0.970 
Substance 
Abuse*Race Yes Black 0 0 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
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Origin US-Born 
vs. Foreign-Born 5.516 2.064 14.74 
Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 55 Somers' D 0.372 
Percent 
Discordant 17.8 Gamma 0.512 
Percent Tied 27.2 Tau-a 0.177 
Pairs 93590 c 0.686         
7. The LOGISTIC 
Procedure Testing 
the Race and HIV 
Status Interaction 
Term.               
Model 
Information 
Data Set OUT.TBGENO3 
Response Variable Clustered 
Number of 
Response Levels 2 
Model binary logit 
Optimization 
Technique Fisher's scoring 
Number of 
Observations 
Read 627 
Number of 
Observations 
Used 627 
Response Profile 
Ordered 
Value Clustered 
Total 
Frequency 
1 Yes 382 
2 No 245 
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Probability 
modeled is 
Clustered='Yes'. 
Class Level 
Information 
Class Value 
Design 
Variables 
Origin US-Born 1 
Foreign-Born -1 
Race Other 1 0 0 
Hispanic/Latino 0 1 0 
Black 0 0 1 
White -1 -1 -1 
HIV Status Yes 1 
No -1 
Model 
Convergence 
Status 
Convergence 
criterion 
(GCONV=1E-8) 
satisfied. 
Model Fit 
Statistics 
Criterion Intercept Only 
Intercept and 
Covariates 
AIC 841.029 773.988 
SC 845.47 809.515 
-2 Log L 839.029 757.988 
Testing Global 
Null Hypothesis: 
BETA=0 
Test Chi-Square DF 
Pr > 
ChiSq 
Likelihood Ratio 81.0412 7 <.001 
Score 81.1609 7 <.001 
Wald 71.8016 7 <.001 
Joint Tests 
Effect DF 
Wald 
Chi-Square 
Pr > 
ChiSq 
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Origin 1 12.1509 0.000 
Race 3 3.066 0.381 
HIV Status 1 0.4352 0.509 
Race*HIV Status 2 0.3986 0.819 
Race Black HIV 
Status Yes = 
Intercept + 3 * 
Race Other - 
Race 
Hispanic/Latino 
- Race Black + 
HIV Status Yes 
+ 3 * Race Other 
HIV Status Yes - 
Race 
Hispanic/Latino 
HIV Status Yes 
Analysis of 
Maximum 
Likelihood 
Estimates 
Parameter DF Est. SE 
Wald 
Chi-
Square 
Pr > 
ChiSq 
Intercept 1 0.01 0.2098 0.007 0.933 
Origin US-Born 1 0.87 0.2512 12.150 0.000 
Race Other 1 0.84 0.8407 1.0024 0.316 
Race Hispanic/Latino 1 
-
0.26 0.528 0.2435 0.621 
Race Black 1 0.16 0.2677 0.3682 0.544 
HIV Status Yes 1 0.12 0.185 0.4352 0.509 
Race*HIV Status Other Yes 1 0.49 0.7813 0.3984 0.527 
Race*HIV Status Hispanic/Latino Yes 1 
-
0.22 0.4951 0.2 0.654 
Race*HIV Status Black Yes 0 0 
Odds Ratio 
Estimates 
Effect Point Estimate 
95% Wald 
 Confidence 
Limits 
Origin US-Born 
vs. Foreign-Born 5.762 2.152 15.42 
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Association of 
Predicted 
Probabilities and 
Observed 
Responses 
Percent 
Concordant 53.2 Somers' D 0.363 
Percent 
Discordant 17 Gamma 0.517 
Percent Tied 29.8 Tau-a 0.173 
Pairs 93590 c 0.681         
 
